{"content":"<li class=\"n-box-item date-title\" data-end=\"1547614799\" data-start=\"1547528400\" data-txt=\"Monday, December 23, 2019\">Tuesday, January 15, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3423330\" data-ts=\"1547593965\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423330-nordstromminus-2_8-on-holiday-sales-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom -2.8% on holiday sales, guidance</a></h4><ul>   <li>Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>) is <font color=\"red\">2.8% lower</font> after hours following its <a href=\"https://seekingalpha.com/pr/17381550-nordstrom-reports-holiday-sales\" target=\"_blank\">holiday sales report and updated guidance</a>.</li>    <li>Comparable sales were up 1.3% for the nine weeks ended Jan. 5, vs. the period ending Jan. 6, 2018.</li>    <li>In Full-Price, comp sales rose 0.3% vs. Q3's YTD gain of 1.9%, amid softer store traffic. Off-Price comp sales rose 3.9%, more consistent with the rest of the year.</li>    <li>Digital sales were up 18% and made up 36% of sales.</li>    <li>YTD comp sales of 2.1% were in line with prior outlook, but Full-Price sales were below expectations, so Nordstrom has incorporated into expectations higher holiday markdowns and to reposition inventory to a more appropriate level by the end of the year.</li>    <li>It says EPS should be toward the low end of previous guidance for $3.27-$3.37 (including Q3 nonrecurring charge of $0.28) or $3.55-$3.65 excluding that charge.</li>    <li>It's scheduled to report Q4 and full-year results after the close on Feb. 28.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3423330\" data-linked=\"Nordstrom -2.8% on holiday sales, guidance\" data-tweet=\"$JWN - Nordstrom -2.8% on holiday sales, guidance https://seekingalpha.com/news/3423330-nordstromminus-2_8-on-holiday-sales-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3423330-nordstromminus-2_8-on-holiday-sales-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423324\" data-ts=\"1547591989\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MERC\" target=\"_blank\">MERC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423324-mercerplus-6_6-on-index-moves-gdot-tfx-changing-indexes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mercer +6.6% on index moves; GDOT, TFX changing indexes</a></h4><ul>   <li>Mercer International (NASDAQ:<a href='https://seekingalpha.com/symbol/MERC' title='Mercer International Inc.'>MERC</a>) is <font color=\"green\">up 6.6%</font> after hours following the latest index musical chairs: It's <a href=\"https://www.spice-indices.com/idpfiles/spice-assets/resources/public/documents/856358_pcg456.pdf?force_download=true\" target=\"_blank\">heading into the S&amp;P SmallCap 600</a>.</li>    <li>It's going there to replace Green Dot (NYSE:<a href='https://seekingalpha.com/symbol/GDOT' title='Green Dot Corporation'>GDOT</a>), which is moving up to the MidCap 400. <a href='https://seekingalpha.com/symbol/GDOT' title='Green Dot Corporation'>GDOT</a> is <font color=\"green\">up 0.1%</font> after hours.</li>    <li>And Green Dot is making its move to replace MidCap 400 constituent Teleflx (NYSE:<a href='https://seekingalpha.com/symbol/TFX' title='Teleflex Inc.'>TFX</a>), which is moving into the S&amp;P 500. <a href='https://seekingalpha.com/symbol/TFX' title='Teleflex Inc.'>TFX</a> is <font color=\"red\">down 0.4%</font> postmarket.</li>    <li>Teleflex will replace PG&amp;E, which is expecting to file for Chapter 11 and isn't eligible to remain in the S&amp;P 500.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3423324\" data-linked=\"Mercer +6.6% on index moves; GDOT, TFX changing indexes\" data-tweet=\"$MERC $MERC $GDOT - Mercer +6.6% on index moves; GDOT, TFX changing indexes https://seekingalpha.com/news/3423324-mercerplus-6_6-on-index-moves-gdot-tfx-changing-indexes?source=tweet\" data-url=\"https://seekingalpha.com/news/3423324-mercerplus-6_6-on-index-moves-gdot-tfx-changing-indexes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423323\" data-ts=\"1547591772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAL\" target=\"_blank\">UAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423323-ual-hl-and-cde-among-notable-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">UAL, HL and CDE among notable after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a> <font color=\"green\">+5.9%</font>. <a href='https://seekingalpha.com/symbol/VSLR' title='Vivint Solar'>VSLR</a> <font color=\"green\">+4.7%</font>. <a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a> <font color=\"green\">+4.2%</font>. <a href='https://seekingalpha.com/symbol/CDE' title='Coeur Mining, Inc.'>CDE</a> <font color=\"green\">+3.8%</font>. <a href='https://seekingalpha.com/symbol/HL' title='Hecla Mining Co.'>HL</a> <font color=\"green\">+3.6%</font>.</li><li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/EFII' title='Electronics for Imaging, Inc.'>EFII</a> <font color=\"red\">-15.4%</font>. <a href='https://seekingalpha.com/symbol/HAFC' title='Hanmi Financial Corporation'>HAFC</a> <font color=\"red\">-8.4%</font>. <a href='https://seekingalpha.com/symbol/FULT' title='Fulton Financial Corporation'>FULT</a> <font color=\"red\">-6.7%</font>. <a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color=\"red\">-5.8%</font>. <a href='https://seekingalpha.com/symbol/MWA' title='Mueller Water Products, Inc.'>MWA</a> <font color=\"red\">-3.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423323\" data-linked=\"UAL, HL and CDE among notable after hour movers\" data-tweet=\"$UAL $UAL $VSLR - UAL, HL and CDE among notable after hour movers https://seekingalpha.com/news/3423323-ual-hl-and-cde-among-notable-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3423323-ual-hl-and-cde-among-notable-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423321\" data-ts=\"1547591337\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423321-snapminus-4_9-cfo-resigns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap -4.9% as CFO resigns</a></h4><ul>   <li>Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) is <font color=\"red\">off 4.9%</font> postmarket after an SEC filing shows that Chief Financial Officer Tim Stone told the company he'd <a href=\"https://seekingalpha.com/filing/4304218\" target=\"_blank\">resign to pursue other opportunities</a>.</li>    <li>The exit isn't related to \"any disagreement with us on any matter relating to our accounting, strategy, management, operations, policies, regulatory matters, or practices (financial or otherwise),\" the company says.</li>    <li>His last day is undetermined and he'll serve in the meantime to help search for a replacement and effect a smooth transition, \"including through our scheduled full year 2018 financial results announcement.\"</li><li>In the same filing, the company says that while it's finalizing its Q4 results, it expects to report revenue and adjusted EBITDA that are \"slightly favorable to the top end\" of previously reported guidance.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3423321\" data-linked=\"Snap -4.9% as CFO resigns\" data-tweet=\"$SNAP - Snap -4.9% as CFO resigns https://seekingalpha.com/news/3423321-snapminus-4_9-cfo-resigns?source=tweet\" data-url=\"https://seekingalpha.com/news/3423321-snapminus-4_9-cfo-resigns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>94&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423317\" data-ts=\"1547590575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FULT\" target=\"_blank\">FULT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423317-fulton-drops-9_0-after-q4-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fulton drops 9.0% after Q4 miss</a></h4><ul><li>Fulton Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/FULT' title='Fulton Financial Corporation'>FULT</a>) <font color=\"red\">sinks 9.0%</font> in after-hours trading after <a href=\"https://seekingalpha.com/pr/17381405-fulton-financial-reports-fourth-quarter-2018-results\" target=\"_blank\">Q4 EPS of 33 cents f</a>alls short of consensus by 2 cents.</li><li>Compares with 37 cents in Q3 and 19 cents in the year-ago quarter.</li><li>Q4 net interest income rose to $162.9M from $160.1Min Q3 and $149.4M in Q4 2017.</li><li>Q4 net interest margin of 3.44% compares with 3.42% in Q3 and 3.29% in the year-ago quarter.</li><li>Q4 net charge-off to average loans increased to 0.17% annualized from 0.08% in Q3 and 0.14% in Q4 2017.</li><li>Effective income tax rate was 8.6% vs. 11.5%% in Q3.</li><li>Separately, Fulton announces that the state of Maryland and the FDIC <a href=\"https://seekingalpha.com/pr/17381433-fulton-financial-announces-termination-consent-orders-columbia-bank\" target=\"_blank\">terminates consent orders</a> relating to Fulton's Columbia Bank subsidiary.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3423288-fulton-financial-misses-0_02-misses-revenue\" target=\"_blank\">Fulton Financial misses by $0.02, misses on revenue</a> (Jan. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3423317\" data-linked=\"Fulton drops 9.0% after Q4 miss\" data-tweet=\"$FULT - Fulton drops 9.0% after Q4 miss https://seekingalpha.com/news/3423317-fulton-drops-9_0-after-q4-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3423317-fulton-drops-9_0-after-q4-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423286\" data-ts=\"1547588071\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAL\" target=\"_blank\">UAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423286-united-continentalplus-5-after-posting-strong-quarter\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Continental +5% after posting strong quarter</a></h4><ul><li>United Continental (NASDAQ:<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a>) rallies after topping estimates with its <a href=\"https://seekingalpha.com/pr/17381361-united-airlines-reports-full-year-fourth-quarter-2018-performance\" target=\"_blank\">Q4</a> report.</li><li>Unit revenue was up 5% Y/Y during the quarter to fall on the top of United's guidance range. Cost per available seat mile rose 7% Y/Y.</li><li>The company also reported an adjusted pre-tax margin of 7.8% vs. 6.9% a year ago.</li><li>Load factor +100 bps to 82.7%.</li><li>Looking ahead, United expects FY19 EPS of $10.00 to $12.00 vs. $10.98 consensus.</li><li>UAL <font color=\"green\">+5.4%</font> AH to $85.65</li><li>Previously: <a href=\"https://seekingalpha.com/news/3423264-united-continental-beats-0_45-beats-revenue\" target=\"_blank\">United Continental beats by $0.45, beats on revenue</a> (Jan. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3423286\" data-linked=\"United Continental +5% after posting strong quarter\" data-tweet=\"$UAL - United Continental +5% after posting strong quarter https://seekingalpha.com/news/3423286-united-continentalplus-5-after-posting-strong-quarter?source=tweet\" data-url=\"https://seekingalpha.com/news/3423286-united-continentalplus-5-after-posting-strong-quarter\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423284\" data-ts=\"1547587928\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HAFC\" target=\"_blank\">HAFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423284-hanmi-sinks-8_5-after-q4-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hanmi sinks 8.5% after Q4 miss</a></h4><ul><li>Hanmi Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/HAFC' title='Hanmi Financial Corporation'>HAFC</a>) <font color=\"red\">plunges </font>8.5% in after-hours trading <a href=\"https://seekingalpha.com/pr/17381324-hanmi-reports-fourth-quarter-2018-results\" target=\"_blank\">Q4 EPS</a> of 37 cents, which includes 9 cents of charges related to tax items.</li><li>Excluding the one-time tax items, Hanmi earned 46 cents per share in the quarter compared with consensus estimate of 51 cents.</li><li>Compares with 50 cents in Q3 and 36 cents in the year-ago quarter.</li><li>\u201cOur results in the fourth quarter reflect our strategic decision to moderate loan growth, protect net interest margin and reduce expenses given the increasingly challenging banking environment,\" says CEO C.G. Kum.</li><li>Q4 net interest income of $45.6M slips 0.7% Q/Q and down 1.5% Y/Y.</li><li>Q4 net interest margin of 3.51% rose from 3.48% in Q3 and fell from 3.79% in Q4 2017.</li><li>Return on average stockholders' equity of 7.92% retreats from 10.91% in Q3 and 8.12% in the year-ago quarter.</li><li><a href=\"https://www.globenewswire.com/Tracker?data=kC4bQrHxBtK02q87L5Fw8-Nyvtf73a2fXSWLTTRNUV5-1tIJZi_3fzlisHmtkYMGKgLBGdWdjnN-WmklIfi-gQ==\" target=\"_blank\">Conference call </a>at 5:00 PM ET.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3423257-hanmi-financial-misses-0_14-beats-revenue\" target=\"_blank\">Hanmi Financial misses by $0.14, beats on revenue</a> (Jan. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3423284\" data-linked=\"Hanmi sinks 8.5% after Q4 miss\" data-tweet=\"$HAFC - Hanmi sinks 8.5% after Q4 miss https://seekingalpha.com/news/3423284-hanmi-sinks-8_5-after-q4-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3423284-hanmi-sinks-8_5-after-q4-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423276\" data-ts=\"1547587733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EFII\" target=\"_blank\">EFII</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423276-efi-reports-downside-preliminary-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EFI reports downside preliminary guidance</a></h4><ul><li>Electronics For Imaging (NASDAQ:<a href='https://seekingalpha.com/symbol/EFII' title='Electronics for Imaging, Inc.'>EFII</a>) <a href=\"https://seekingalpha.com/pr/17381325-efi-announces-preliminary-results-fourth-quarter-2018\" target=\"_blank\">reports</a> preliminary Q4 results with revenue of $255M to $257M (consensus: $280.7M) and EPS of $0.45 to $0.47.</li><li>Cash flow from operating activities is expected to be $30M to $33M.</li><li>EFII says the results were \"impacted by weakening economic conditions experienced across its direct businesses, with customers delaying spend on capital equipment and software.\"</li><li>The company will hold a conference call at 5 PM ET today to discuss the preliminary results with a webcast available <a href=\"https://seekingalpha.com/pr/17381325-efi-announces-preliminary-results-fourth-quarter-2018\" target=\"_blank\">here</a>.</li><li>EFII shares were halted ahead of the news.</li><li>Update: EFII resumes trading <font color=\"red\">down 10%</font> to $24.48.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423276\" data-linked=\"EFI reports downside preliminary guidance\" data-tweet=\"$EFII - EFI reports downside preliminary guidance https://seekingalpha.com/news/3423276-efi-reports-downside-preliminary-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3423276-efi-reports-downside-preliminary-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423268\" data-ts=\"1547587316\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RVNC\" target=\"_blank\">RVNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423268-revance-readies-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Revance readies stock offering</a></h4><ul><li>Revance Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/RVNC' title='Revance Therapeutics, Inc.'>RVNC</a>) <a href=\"https://seekingalpha.com/pr/17381364-revance-announces-proposed-public-offering-common-stock\" target=\"_blank\">initiates </a>a $100M public stock offering. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423268\" data-linked=\"Revance readies stock offering\" data-tweet=\"$RVNC - Revance readies stock offering https://seekingalpha.com/news/3423268-revance-readies-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3423268-revance-readies-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423264\" data-ts=\"1547587091\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAL\" target=\"_blank\">UAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423264-united-continental-beats-0_45-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">United Continental beats by $0.45, beats on revenue</a></h4><ul><li>United Continental (NASDAQ:<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a>): Q4 Non-GAAP EPS of $2.41 <span style=\"color:green\">beats by $0.45</span>; GAAP EPS of $1.70 <span style=\"color:red\">misses by $0.17</span>.</li><li>Revenue of $10.49B (+11.0% Y/Y) <font color=\"green\">beats by $130M</font>.</li><li>Shares <font color=\"green\">+3%</font>.</li><li><a href=\"https://seekingalpha.com/pr/17381361-united-airlines-reports-full-year-fourth-quarter-2018-performance\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3423264\" data-linked=\"United Continental beats by $0.45, beats on revenue\" data-tweet=\"$UAL - United Continental beats by $0.45, beats on revenue https://seekingalpha.com/news/3423264-united-continental-beats-0_45-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3423264-united-continental-beats-0_45-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423239\" data-ts=\"1547585182\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IPHI\" target=\"_blank\">IPHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423239-inphiplus-5-on-q1-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inphi +5% on Q1 guidance</a></h4><ul><li>Inphi (NYSE:<a href='https://seekingalpha.com/symbol/IPHI' title='Inphi Corporation'>IPHI</a>) <font color=\"green\">gains 5.2%</font> after CEO Ford Tamer speaks at the Needham Growth Conference and guides mid-30s percent revenue growth Y/Y in the first quarter compared to the 36% consensus estimate.</li><li>Inphi reports earnings on January 29.</li><li>Source: Bloomberg First Word.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423239\" data-linked=\"Inphi +5% on Q1 guidance\" data-tweet=\"$IPHI - Inphi +5% on Q1 guidance https://seekingalpha.com/news/3423239-inphiplus-5-on-q1-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3423239-inphiplus-5-on-q1-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423238\" data-ts=\"1547585115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423238-british-pound-erases-days-loss-after-brexit-vote\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">British pound erases day&#39;s loss after Brexit vote</a></h4><ul><li>British pound erases its earlier loss and <font color=\"green\">strengthens 0.2% </font>against the dollar in late afternoon in U.S. ET after Theresa May's Brexit plan is overwhelmingly rejected by Parliament.</li><li>Before the vote, the pound had weakened as much as 1.5% against the dollar.</li><li>iShares MSCI United Kingdom (NYSEARCA:<a href='https://seekingalpha.com/symbol/EWU' title='iShares MSCI United Kingdom ETF'>EWU</a>) <font color=\"green\">+0.4%</font>; had been down as much as 0.7% earlier.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3423217-mays-government-face-confidence-vote\" target=\"_blank\">May's government to face no-confidence vote</a> (Jan. 15)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/FXB' title='Invesco CurrencyShares British Pound Sterling Trust ETF'>FXB</a>, <a href='https://seekingalpha.com/symbol/EWU' title='iShares MSCI United Kingdom ETF'>EWU</a>, <a href='https://seekingalpha.com/symbol/GBB' title='iPath GBP/USD Exchange Rate ETN'>OTC:GBB</a>, <a href='https://seekingalpha.com/symbol/DBUK' title='Deutsche X-trackers MSCI United Kingdom Hedged Equity ETF'>DBUK</a>, <a href='https://seekingalpha.com/symbol/FKU' title='First Trust United Kingdom AlphaDex ETF'>FKU</a>,  <a href='https://seekingalpha.com/symbol/HEWU' title='iShares Currency Hedged MSCI United Kingdom ETF'>HEWU</a>, <a href='https://seekingalpha.com/symbol/QGBR' title='SPDR MSCI United Kingdom Quality Mix ETF'>QGBR</a>, <a href='https://seekingalpha.com/symbol/DGBP' title='VelocityShares Daily 4X Long USD vs. GBP ETN'>DGBP</a>, <a href='https://seekingalpha.com/symbol/FLGB' title='Franklin FTSE United Kingdom ETF'>FLGB</a>, <a href='https://seekingalpha.com/symbol/UGBP' title='VelocityShares Daily 4X Long GBP vs. USD ETN'>UGBP</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3423238\" data-linked=\"British pound erases day&#39;s loss after Brexit vote\" data-tweet=\"$EWU $FXB $GBB - British pound erases day&#39;s loss after Brexit vote https://seekingalpha.com/news/3423238-british-pound-erases-days-loss-after-brexit-vote?source=tweet\" data-url=\"https://seekingalpha.com/news/3423238-british-pound-erases-days-loss-after-brexit-vote\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423236\" data-ts=\"1547584779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BELFA\" target=\"_blank\">BELFA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423236-bel-provides-q418-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bel provides Q418 update</a></h4><ul><li>Bel Fuse Inc (<a href='https://seekingalpha.com/symbol/BELFA' title='Bel Fuse Inc.'>BELFA</a>) <a href=\"https://seekingalpha.com/pr/17381266-bel-provides-fourth-quarter-2018-update\" target=\"_blank\">expects</a> Q4 revenue of $143M (+19% Y/Y) vs. a consensus of $136M.</li><li>Full year 2018 sales of ~$548M (+11.5% Y/Y) vs. a consensus of $541.5M.</li><li>Annual bookings for 2018 to ~$578M as compared to $516M in 2017.</li><li>The Company\u2019s backlog of orders was $171.2M (+17% Y/Y) at Dec 31, 2018.</li><li>The Company expects to report its preliminary financial results on Feb. 21, 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423236\" data-linked=\"Bel provides Q418 update\" data-tweet=\"$BELFA $BELFB - Bel provides Q418 update https://seekingalpha.com/news/3423236-bel-provides-q418-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3423236-bel-provides-q418-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:39 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423235\" data-ts=\"1547584690\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVCO\" target=\"_blank\">AVCO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423235-avalon-globocare-files-for-50m-mixed-shelf-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avalon Globocare files for $50M mixed shelf offering</a></h4><ul><li>Avalon Globocare (<a href='https://seekingalpha.com/symbol/AVCO' title='Avalon GloboCare Corp.'>OTCQB:AVCO</a> <font color=\"green\">+2%</font>) has filed a preliminary <a href=\"https://www.sec.gov/Archives/edgar/data/1630212/000161577419000637/s115361_s3a.htm\" target=\"_blank\">prospectus </a>for a $50M mixed shelf offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423235\" data-linked=\"Avalon Globocare files for $50M mixed shelf offering\" data-tweet=\"$AVCO - Avalon Globocare files for $50M mixed shelf offering https://seekingalpha.com/news/3423235-avalon-globocare-files-for-50m-mixed-shelf-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3423235-avalon-globocare-files-for-50m-mixed-shelf-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423227\" data-ts=\"1547584519\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRY\" target=\"_blank\">TLRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423227-tilray-under-pressure-on-expiration-of-lockup-period-down-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tilray under pressure on expiration of lockup period, down 18%</a></h4><ul><li>Cannabis producer Tilray (<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color=\"red\">-17.8%</font>) is down on almost a 5x surge in volume approaching the end of the session. The lockup period <a href=\"https://www.thestreet.com/investing/cannabis/tilray-extends-gains-as-july-2018-ipo-lock-up-expires-for-cannabis-group-14833952\" target=\"_blank\">expired today</a>. Although top shareholder Privateer Holdings <a href=\"https://seekingalpha.com/news/3422332-privateer-stays-course-tilray-investment\" target=\"_blank\">stated</a> that it was holding on to its 76% stake (~75M shares), about 8M were expected to be released today.</li><li>The company debuted on Nasdaq on July 15, 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423227\" data-linked=\"Tilray under pressure on expiration of lockup period, down 18%\" data-tweet=\"$TLRY - Tilray under pressure on expiration of lockup period, down 18% https://seekingalpha.com/news/3423227-tilray-under-pressure-on-expiration-of-lockup-period-down-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3423227-tilray-under-pressure-on-expiration-of-lockup-period-down-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423223\" data-ts=\"1547583842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TLRY\" target=\"_blank\">TLRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423223-ag-nominee-barr-wont-go-after-pot-companies\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AG nominee Barr won&#39;t &quot;go after&quot; pot companies</a></h4><ul><li>At his <a href=\"https://www.apnews.com/65c8848eae6947aabd5957ed21ce70cf\" target=\"_blank\">confirmation hearing</a>, Attorney General nominee William Barr said that he would not \"go after\" marijuana companies in states allowing cannabis use, adding that the current system (cannabis use and possession is illegal on the federal level) is \"untenable.\"</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color=\"red\">-17.1%</font>)(<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a> <font color=\"red\">-4.6%</font>)(<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color=\"red\">-1.4%</font>)(<a href='https://seekingalpha.com/symbol/MJNA' title='Medical Marijuana, Inc.'>OTCPK:MJNA</a> <font color=\"red\">-5.4%</font>)(<a href='https://seekingalpha.com/symbol/ACB' title='Aurora Cannabis Inc.'>ACB</a> <font color=\"green\">+5.3%</font>)(<a href='https://seekingalpha.com/symbol/PHOT' title='Growlife Inc.'>OTCQB:PHOT</a> <font color=\"red\">-4.9%</font>)(<a href='https://seekingalpha.com/symbol/CBIS' title='Cannabis Science, Inc.'>OTCPK:CBIS</a> <font color=\"red\">-3.3%</font>)(<a href='https://seekingalpha.com/symbol/APHA' title='Aphria Inc.'>APHA</a> <font color=\"red\">-3.1%</font>)(<a href='https://seekingalpha.com/symbol/TRTC' title='Terra Tech Corp.'>OTCQX:TRTC</a> <font color=\"red\">-0.2%</font>)(<a href='https://seekingalpha.com/symbol/CANN' title='General Cannabis Corp.'>OTCQX:CANN</a> <font color=\"red\">-10.5%</font>)(<a href='https://seekingalpha.com/symbol/GRNH' title='GreenGro Technologies, Inc.'>OTCPK:GRNH</a> <font color=\"green\">+5%</font>)(<a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a> <font color=\"red\">-1.5%</font>)(<a href='https://seekingalpha.com/symbol/HEMP' title='Hemp, Inc.'>OTCPK:HEMP</a> <font color=\"red\">-9%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3423223\" data-linked=\"AG nominee Barr won&#39;t &quot;go after&quot; pot companies\" data-tweet=\"$TLRY $TLRY $CRON - AG nominee Barr won&#39;t &quot;go after&quot; pot companies https://seekingalpha.com/news/3423223-ag-nominee-barr-wont-go-after-pot-companies?source=tweet\" data-url=\"https://seekingalpha.com/news/3423223-ag-nominee-barr-wont-go-after-pot-companies\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>54&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423222\" data-ts=\"1547583733\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423222-goodyear-tire-rubber-sinks-to-52-week-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goodyear Tire &amp; Rubber sinks to 52-week low</a></h4><ul><li>Shares of Goodyear Tire &amp; Rubber (<a href='https://seekingalpha.com/symbol/GT' title='Goodyear Tire & Rubber Co.'>GT</a> <font color='red'>-14.2%</font>) plunge after the company ran through a litany of issues that held back Q4 tire volume.</li><li>Issues impacting demand were seen in China, Europe, India and the U.S., according to execs presenting at an investor conference.</li><li>Goodyear traded at a 52-week low of $18.67 minutes ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3423162-goodyear-tire-and-rubber-minus-3-percent-disclosing-volume-drop\" target=\"_blank\">Goodyear Tire &amp; Rubber -3% after disclosing volume drop</a> (Jan. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3423222\" data-linked=\"Goodyear Tire &amp; Rubber sinks to 52-week low\" data-tweet=\"$GT - Goodyear Tire &amp; Rubber sinks to 52-week low https://seekingalpha.com/news/3423222-goodyear-tire-rubber-sinks-to-52-week-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3423222-goodyear-tire-rubber-sinks-to-52-week-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423221\" data-ts=\"1547583015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALO\" target=\"_blank\">ALO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423221-alio-gold-eyes-rising-production-for-florida-canyon-mine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alio Gold eyes rising production for Florida Canyon mine</a></h4><ul><li>Alio Gold (<a href='https://seekingalpha.com/symbol/ALO' title='Alio Gold Inc'>ALO</a> <font color='red'>-4.7%</font>) says its <a href=\"https://seekingalpha.com/pr/17379996-alio-gold-announces-updated-life-mine-plan-florida-canyon\" target=\"_blank\">updated life-of-mine plan</a> for the Florida Canyon Mine in Nevada forecasts total gold  production of 734K oz. over a 9.8-year mine life.</li><li>ALO says its plan shows total proven and  probable mineral reserves of 1.01M oz. of gold based on a  pit designed to maximize project economics at $1,250/oz. gold.</li><li>Florida Canyon produced 47.4K oz. of gold in 2018, and the company expects the mine to produce ~60K oz. in 2019 at a cash cost of ~$1K/oz. before averaging 75K oz. annually for the next eight years.</li><li>ALO says it will evaluate opportunities to enhance the value of Florida Canyon in 2019 including the restart of the adjacent Standard Mine and the strategic value of the sulfide deposit underlying the oxide reserves.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423221\" data-linked=\"Alio Gold eyes rising production for Florida Canyon mine\" data-tweet=\"$ALO - Alio Gold eyes rising production for Florida Canyon mine https://seekingalpha.com/news/3423221-alio-gold-eyes-rising-production-for-florida-canyon-mine?source=tweet\" data-url=\"https://seekingalpha.com/news/3423221-alio-gold-eyes-rising-production-for-florida-canyon-mine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423220\" data-ts=\"1547582441\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHC\" target=\"_blank\">VHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423220-microcaps-dominate-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps dominate tech movers</a></h4><ul><li><strong>Gainers: </strong>VirnetX Holding (NYSEMKT:<a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a>) <font color=\"green\">+53%</font>. Sonic Foundry (<a href='https://seekingalpha.com/symbol/SOFO' title='Sonic Foundry, Inc.'>OTC:SOFO</a>) <font color=\"green\">+34%</font>. BSQUARE Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/BSQR' title='BSQUARE Corporation'>BSQR</a>) <font color=\"green\">+32%</font>. Resonant (NASDAQ:<a href='https://seekingalpha.com/symbol/RESN' title='Resonant'>RESN</a>) <font color=\"green\">+29%</font>. FTE Networks (NYSEMKT:<a href='https://seekingalpha.com/symbol/FTNW' title='FTE Networks, Inc.'>FTNW</a>) <font color=\"green\">+13%</font>.</li> <li><strong>Losers: </strong>Internet Gold - Golden Lines (NASDAQ:<a href='https://seekingalpha.com/symbol/IGLD' title='Internet Gold Golden Lines Ltd.'>IGLD</a>) <font color=\"red\">-19%</font>. Maxar Technologies (NYSE:<a href='https://seekingalpha.com/symbol/MAXR' title='Maxar Technologies Inc'>MAXR</a>) <font color=\"red\">-12%</font>. Sphere 3D (NASDAQ:<a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a>) <font color=\"red\">-11%</font>. Aehr Test Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/AEHR' title='Aehr Test Systems'>AEHR</a>) <font color=\"red\">-10%</font>. OptimizeRx (NASDAQ:<a href='https://seekingalpha.com/symbol/OPRX' title='OptimizeRx Corp.'>OPRX</a>) <font color=\"red\">-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3423220\" data-linked=\"Microcaps dominate tech movers\" data-tweet=\"$VHC $VHC $SOFO - Microcaps dominate tech movers https://seekingalpha.com/news/3423220-microcaps-dominate-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3423220-microcaps-dominate-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423216\" data-ts=\"1547581955\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423216-chipotle-icr-tv-ads-testing-on-new-menu-items\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chipotle at ICR: More TV ads, testing on new menu items</a></h4><ul><li>Chipotle (<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a> <font color='green'>+1.9%</font>) is allocating more money to TV advertisements and social media engagement, according to execs today speaking at the ICR conference.</li><li>\"The brand just became invisible. And we are working to make it more visible,\" sums up CEO Brian Niccol on the strategy.</li><li>On the topic of menu innovation, Chipotle revealed at ICR that nachos, tostadas and chocolate shakes are all in testing phase. Still, the company plans to take a cautious approach before commiting to any national rollouts for the products.</li><li>Shares of Chipotle are starting 2019 on an upswing, up 19% YTD already including today's rally.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423216\" data-linked=\"Chipotle at ICR: More TV ads, testing on new menu items\" data-tweet=\"$CMG - Chipotle at ICR: More TV ads, testing on new menu items https://seekingalpha.com/news/3423216-chipotle-icr-tv-ads-testing-on-new-menu-items?source=tweet\" data-url=\"https://seekingalpha.com/news/3423216-chipotle-icr-tv-ads-testing-on-new-menu-items\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423215\" data-ts=\"1547581619\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EIX\" target=\"_blank\">EIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423215-edison-cut-to-sell-baml-on-californias-challenging-operating-environment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Edison cut to Sell at BAML on California&#39;s &#39;challenging operating environment&#39;</a></h4><ul><li>Edison International (<a href='https://seekingalpha.com/symbol/EIX' title='Edison International'>EIX</a> <font color='red'>-5.6%</font>) is <a href=\"https://thefly.com/thestreet/realmoney/index.php/EIXid2848751/EIX-Edison-International-downgraded-to-Underperform-from-Neutral-at-BofAMerrill\" target=\"_blank\">downgraded</a> to Underperform from Neutral with a $61 price target, trimmed from $64, at BofA Merrill Lynch, which cites the challenging operating environment in California following the PG&amp;E Chapter 11 filing.</li><li>BAML analyst Julien Dumoulin-Smith says shares are not \"investable\" until there is clear legislation that limits inverse condemnation and related liabilities.</li><li>\"Bankruptcy is PG&amp;E\u2019s response to the risk\" of inverse condemnation, says Severin Borenstein of the Energy Institute at the Haas School of Business at Cal-Berkeley. \"That leads to the larger question of whether or not this bankruptcy leads to... how we have utilities in California, and <a href=\"https://www.reuters.com/article/us-pg-e-us-bankruptcy-law/pge-restructuring-highlights-arcane-california-legal-rule-idUSKCN1P91BY\" target=\"_blank\">if we move from private firms to government owned</a>.\"</li><li>EIX shares have fallen ~20% since Nov. 8, when the northern California fires began to take down PG&amp;E.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423215\" data-linked=\"Edison cut to Sell at BAML on California&#39;s &#39;challenging operating environment&#39;\" data-tweet=\"$EIX - Edison cut to Sell at BAML on California&#39;s &#39;challenging operating environment&#39; https://seekingalpha.com/news/3423215-edison-cut-to-sell-baml-on-californias-challenging-operating-environment?source=tweet\" data-url=\"https://seekingalpha.com/news/3423215-edison-cut-to-sell-baml-on-californias-challenging-operating-environment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423210\" data-ts=\"1547580509\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423210-pg-and-e-misses-interest-payment-on-2040-notes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E misses interest payment on 2040 notes</a></h4><ul><li>Nearly all of PG&amp;E's (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-19.7%</font>) $18B in bonds trade lower after the company <a href=\"https://www.reuters.com/article/us-pg-e-us-bankruptcy-debt/pge-misses-interest-payment-on-2024-notes-bonds-shares-plummet-idUSKCN1P92AC?il=0\" target=\"_blank\">failed to make a $21.6M interest payment</a> due today on its 2040 senior notes.</li><li>In response to a request for comment, the company notes the \"30-day grace period to make the interest payment before triggering an event of default.\"</li><li>The price of the 2040 bond, which is worth $800M and has a 5.4% coupon rate, is 4.75 points lower today with its yield spread vs. U.S. Treasury securities rising by 4.77 percentage points.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423210\" data-linked=\"PG&amp;E misses interest payment on 2040 notes\" data-tweet=\"$PCG - PG&amp;E misses interest payment on 2040 notes https://seekingalpha.com/news/3423210-pg-and-e-misses-interest-payment-on-2040-notes?source=tweet\" data-url=\"https://seekingalpha.com/news/3423210-pg-and-e-misses-interest-payment-on-2040-notes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423206\" data-ts=\"1547579938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFO\" target=\"_blank\">INFO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423206-ihs-markitplus-2_5-after-double-digit-revenue-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IHS Markit +2.5% after double-digit revenue gains</a></h4><ul>   <li>IHS Markit (NASDAQ:<a href='https://seekingalpha.com/symbol/INFO' title='IHS Markit Ltd.'>INFO</a>) is <font color=\"green\">up 2.5%</font> today after topping profit expectations with double-digit revenue gains in Q4.</li>    <li>Gains in Transportation and Financial Services paced an overall 13% gain in revenues, which fell a hair short of consensus.</li>    <li>On an organic basis, revenues rose 5%.</li>    <li>Cash flow from operations came in at $358M; free cash flow was $303M.</li>    <li>Revenue by segment: Resources, $223M (up 3%); Transportation, $297M (up 11%); Consolidated Markets &amp; Solutions, $139M (down 1%); Financial Services, $409M (up 27%).</li>    <li>For the coming year, it's guiding to revenues of $4.425B-$4.5B (vs. consensus for $4.48B); that includes organic growth of 5-6% (including Ipreo for a four-month stub period) or 6-7% (including Ipreo for the full 12 months).</li>    <li>It also sees EBITDA of $1.75B-$1.78B and EPS of $2.52-$2.57 (vs. consensus for $2.56).</li>    <li><a href=\"https://seekingalpha.com/article/4233492-ihs-markit-ltd-2018-q4-results-earnings-call-slides\" target=\"_blank\">Earnings call slides</a></li><li>Previously: <a href=\"https://seekingalpha.com/news/3422964-ihs-markit-beats-0_02-misses-revenue\" target=\"_blank\">IHS Markit beats by $0.02, misses on revenue</a> (Jan. 15 2019)</li>    <li><a href=\"https://www.businesswire.com/news/home/20190115005347/en/\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3423206\" data-linked=\"IHS Markit +2.5% after double-digit revenue gains\" data-tweet=\"$INFO - IHS Markit +2.5% after double-digit revenue gains https://seekingalpha.com/news/3423206-ihs-markitplus-2_5-after-double-digit-revenue-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3423206-ihs-markitplus-2_5-after-double-digit-revenue-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423205\" data-ts=\"1547579922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETQ\" target=\"_blank\">PETQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423205-petiq-soars-after-icr-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PetIQ soars after ICR presentation</a></h4><ul><li>PetIQ (<a href='https://seekingalpha.com/symbol/PETQ' title='PetIQ'>PETQ</a> <font color='green'>+13.1%</font>) soars after the company says during its ICR presentation that it aims to double annual sales to over $1B in the long term.</li><li>PetIQ is also targeting 25% EPS growth.</li><li><a href=\"http://ir.petiq.com/phoenix.zhtml?c=254371&amp;p=irol-calendar\" target=\"_blank\">PetIQ conference presentation webcast</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3423205\" data-linked=\"PetIQ soars after ICR presentation\" data-tweet=\"$PETQ - PetIQ soars after ICR presentation https://seekingalpha.com/news/3423205-petiq-soars-after-icr-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3423205-petiq-soars-after-icr-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423204\" data-ts=\"1547579856\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TENB\" target=\"_blank\">TENB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423204-tenableplus-12_7-morgan-stanley-leaves-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenable +12.7% as Morgan Stanley leaves sidelines</a></h4><ul><li>Tenable (<a href='https://seekingalpha.com/symbol/TENB' title='Tenable Holdings'>TENB</a> <font color='green'>+12.5%</font>) <font color=\"green\">gains 12.7%</font> after Morgan Stanley upgrades the company from Equal-Weight to Overweight and raises the target by a dollar to $31.</li><li>The firm names Tenable among its \"secularly attractive security names now trading at a meaningful discount to growth.\"</li><li>Source: Bloomberg First Word.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423204\" data-linked=\"Tenable +12.7% as Morgan Stanley leaves sidelines\" data-tweet=\"$TENB - Tenable +12.7% as Morgan Stanley leaves sidelines https://seekingalpha.com/news/3423204-tenableplus-12_7-morgan-stanley-leaves-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3423204-tenableplus-12_7-morgan-stanley-leaves-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423199\" data-ts=\"1547578752\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VHI\" target=\"_blank\">VHI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423199-valhi-and-aceto-among-energy-materials-gainers-legacy-reserves-and-pedevco-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valhi and Aceto among Energy/Materials gainers; Legacy Reserves and PEDEVCO among losers</a></h4><ul><li><b>Gainers: </b>Valhi (NYSE:<a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a>) <font color=\"green\">+23%</font>. Aceto (NASDAQ:<a href='https://seekingalpha.com/symbol/ACET' title='Aceto Corporation'>ACET</a>) <font color=\"green\">+19%</font>. Quintana Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/QES' title='Quintana Energy Services Inc.'>QES</a>) <font color=\"green\">+8%</font>. Superior Drilling Products (NYSEMKT:<a href='https://seekingalpha.com/symbol/SDPI' title='Superior Drilling Products, Inc.'>SDPI</a>) <font color=\"green\">+8%</font>. Ossen Innovation (NASDAQ:<a href='https://seekingalpha.com/symbol/OSN' title='Ossen Innovation Co., Ltd.'>OSN</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers: </b>Legacy Reserves (NASDAQ:<a href='https://seekingalpha.com/symbol/LGCY' title='Legacy Reserves Inc'>LGCY</a>) <font color=\"red\">-13%</font>. PEDEVCO (NYSEMKT:<a href='https://seekingalpha.com/symbol/PED' title='PEDEVCO Corp.'>PED</a>) <font color=\"red\">-12%</font>. First Majestic Silver (NYSE:<a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a>) <font color=\"red\">-10%</font>. Coeur Mining (NYSE:<a href='https://seekingalpha.com/symbol/CDE' title='Coeur Mining, Inc.'>CDE</a>) <font color=\"red\">-8%</font>. Venator Materials (NYSE:<a href='https://seekingalpha.com/symbol/VNTR' title='Venator Materials'>VNTR</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423199\" data-linked=\"Valhi and Aceto among Energy/Materials gainers; Legacy Reserves and PEDEVCO among losers\" data-tweet=\"$VHI $VHI $ACET - Valhi and Aceto among Energy/Materials gainers; Legacy Reserves and PEDEVCO among losers https://seekingalpha.com/news/3423199-valhi-and-aceto-among-energy-materials-gainers-legacy-reserves-and-pedevco-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3423199-valhi-and-aceto-among-energy-materials-gainers-legacy-reserves-and-pedevco-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:59 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423194\" data-ts=\"1547576907\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423194-bristol-myers-gets-two-notch-upgrade-post-celgene-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristol-Myers gets two-notch upgrade post-Celgene deal</a></h4><ul><li>ScoGen was previously the only sell-side shop with a Sell rating on Bristol-Myers Squibb (NYSE:<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a>), but is a big fan of the Celgene (NASDAQ:<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a>) acquisition, and upgrades all the way to Buy.</li><li>The team figures the purchase will add $17 per share to BMY's stock price (which currently sits just south of $50), and estimates there's an 80% chance of the deal closing.</li><li>Shares are <font color=\"green\">up 2.8%</font> today.</li><li>Source: Bloomberg</li></ul><div class=\"tiny-share-widget\" data-id=\"3423194\" data-linked=\"Bristol-Myers gets two-notch upgrade post-Celgene deal\" data-tweet=\"$BMY $BMY $CELG - Bristol-Myers gets two-notch upgrade post-Celgene deal https://seekingalpha.com/news/3423194-bristol-myers-gets-two-notch-upgrade-post-celgene-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3423194-bristol-myers-gets-two-notch-upgrade-post-celgene-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423188\" data-ts=\"1547575010\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QFIN\" target=\"_blank\">QFIN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423188-360-finance-leads-financial-gainers-maiden-holdings-and-lm-funding-america-only-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">360 Finance leads financial gainers; Maiden Holdings and LM Funding America the only losers</a></h4><ul><li><b>Gainers:</b> 360 Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/QFIN' title='360 Finance'>QFIN</a>) <font color=\"green\">+26%</font>. The RMR Group (NASDAQ:<a href='https://seekingalpha.com/symbol/RMR' title='The RMR Group Inc.'>RMR</a>) <font color=\"green\">+15%</font>. First Republic Bank (NYSE:<a href='https://seekingalpha.com/symbol/FRC' title='First Republic Bank'>FRC</a>) <font color=\"green\">+12%</font>. Hexindai (NASDAQ:<a href='https://seekingalpha.com/symbol/HX' title='Hexindai Inc.'>HX</a>) <font color=\"green\">+7%</font>. Fanhua (NASDAQ:<a href='https://seekingalpha.com/symbol/FANH' title='Fanhua Inc.'>FANH</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers:</b> Maiden Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/MHLD' title='Maiden Hldgs Ltd'>MHLD</a>) <font color=\"red\">-8%</font>. LM Funding America (NASDAQ:<a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423188\" data-linked=\"360 Finance leads financial gainers; Maiden Holdings and LM Funding America the only losers\" data-tweet=\"$QFIN $QFIN $RMR - 360 Finance leads financial gainers; Maiden Holdings and LM Funding America the only losers https://seekingalpha.com/news/3423188-360-finance-leads-financial-gainers-maiden-holdings-and-lm-funding-america-only-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3423188-360-finance-leads-financial-gainers-maiden-holdings-and-lm-funding-america-only-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423183\" data-ts=\"1547574201\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTOV\" target=\"_blank\">KTOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423183-vhc-mbot-pcg-and-chfs-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VHC, MBOT, PCG and CHFS among midday movers</a></h4><ul><li><strong>Gainers: </strong>Kitov Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/KTOV' title='Kitov Pharma Ltd.'>KTOV</a>) <font color=\"green\">+159%</font>. Microbot Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a>) <font color=\"green\">+81%</font>. Blue Apron Holdings (NYSE:<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>) <font color=\"green\">+38%</font>. VirnetX Holding (NYSEMKT:<a href='https://seekingalpha.com/symbol/VHC' title='VirnetX Holding Corporation'>VHC</a>) <font color=\"green\">+35%</font>. BSQUARE Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/BSQR' title='BSQUARE Corporation'>BSQR</a>) <font color=\"green\">+32%</font>. Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) <font color=\"green\">+29%</font>. Resonant (NASDAQ:<a href='https://seekingalpha.com/symbol/RESN' title='Resonant'>RESN</a>) <font color=\"green\">+28%</font>. CHF Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a>) <font color=\"green\">+23%</font>. 360 Finance (NASDAQ:<a href='https://seekingalpha.com/symbol/QFIN' title='360 Finance'>QFIN</a>) <font color=\"green\">+23%</font>. Valhi (NYSE:<a href='https://seekingalpha.com/symbol/VHI' title='Valhi, Inc.'>VHI</a>) <font color=\"green\">+21%</font>.</li> <li><strong>Losers: </strong>Estre Ambiental (NASDAQ:<a href='https://seekingalpha.com/symbol/ESTR' title='Estre Ambiental, Inc.'>ESTR</a>) <font color=\"red\">-35%</font>. PG&amp;E Corporation (NYSE:<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a>) <font color=\"red\">-21%</font>. Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) <font color=\"red\">-19%</font>. Internet Gold - Golden Lines (NASDAQ:<a href='https://seekingalpha.com/symbol/IGLD' title='Internet Gold Golden Lines Ltd.'>IGLD</a>) <font color=\"red\">-19%</font>. Future FinTech Group (NASDAQ:<a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a>) <font color=\"red\">-17%</font>. Stellar Biotechnologies, Inc. (NASDAQ:<a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a>) <font color=\"red\">-14%</font>. Constellation Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/CNST' title='Constellation Pharmaceuticals'>CNST</a>) <font color=\"red\">-12%</font>. Co-Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics'>CODX</a>) <font color=\"red\">-12%</font>. Tilray (NASDAQ:<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>) <font color=\"red\">-11%</font>. Sphere 3D (NASDAQ:<a href='https://seekingalpha.com/symbol/ANY' title='Sphere 3D Corp.'>ANY</a>) <font color=\"red\">-11%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3423183\" data-linked=\"VHC, MBOT, PCG and CHFS among midday movers\" data-tweet=\"$KTOV $KTOV $MBOT - VHC, MBOT, PCG and CHFS among midday movers https://seekingalpha.com/news/3423183-vhc-mbot-pcg-and-chfs-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3423183-vhc-mbot-pcg-and-chfs-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423182\" data-ts=\"1547574079\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423182-analysts-back-netflix-pricing-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts back Netflix pricing action</a></h4><ul><li>Piper Jaffray is out of the gate with a positive note on the prices hikes at Netflix (<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a> <font color='green'>+6.9%</font>).</li><li>Surveys indicate Netflix has plenty of pricing flexbility with customers before churn is a significant issue, according to the firm.</li><li>RBC Capital Markets analyst Mark Mahaney sees a <a href=\"https://www.cnbc.com/video/2019/01/15/netflix-flexing-pricing-muscles-price-hike-analyst.html\" target=\"_blank\">$1B</a> incremental boost to the top line from the price increase in the U.S. Mahaney thinks a good portion of the extra revenue will go toward meeting content obligations, but some amount will make its way down to Netflix's bottom line.</li><li>SunTrust analyst Matthew Thornton says the pricing action from Netflix makes sense with the upcoming content slate from the streamer very strong.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3423089-netflix-plus-5-percent-report-price-hikes\" target=\"_blank\">Netflix +5% on report of price hikes</a> (Jan. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3423182\" data-linked=\"Analysts back Netflix pricing action\" data-tweet=\"$NFLX - Analysts back Netflix pricing action https://seekingalpha.com/news/3423182-analysts-back-netflix-pricing-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3423182-analysts-back-netflix-pricing-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423177\" data-ts=\"1547572912\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NEM\" target=\"_blank\">NEM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423177-investors-slam-8m-payout-due-goldcorp-ceo-from-newmont-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors slam $8M payout due Goldcorp CEO from Newmont deal</a></h4><ul><li>A group of gold investors including John Paulson criticizes Newmont Mining\u2019s (<a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a> <font color='red'>-2.3%</font>) <a href=\"https://seekingalpha.com/news/3422587-newmont-mining-goldcorp-combine-10b-stock-deal\" target=\"_blank\">planned $10B acquisition</a> of Goldcorp (<a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a> <font color='red'>-1.8%</font>) and the <a href=\"https://www.ft.com/content/709fe38c-18ae-11e9-9e64-d150b3105d21\" target=\"_blank\">~$8M reward due CEO David Garofalo</a> from the deal.</li><li>The Shareholders\u2019 Gold Council, formed last year to promote the interests of gold investors, said Garofalo had been \u201cmassively overpaid\u201d since his appointment in 2016 - more than $16M in 2016-17 combined - while shares have fallen by 26% under the CEO; now Garofalo stands to reap another $8M due to change of control provisions in his contract.</li><li>\u201cWhile Garofalo has been massively overpaid, stockholders have lost over C$3.7B since his appointment, and Goldcorp now wants to sell itself at only a slight premium to its one-, three-, five-, seven- and 10-year low in share price,\u201d the Shareholders\u2019 Gold Council says.</li><li>NEM CEO Gary Goldberg is expected to remain in his  position to close the acquisition, then COO Tom Palmer will take over; it is not yet clear whether Garofalo will stay on at the combined company following the deal.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423177\" data-linked=\"Investors slam $8M payout due Goldcorp CEO from Newmont deal\" data-tweet=\"$NEM $NEM $GG - Investors slam $8M payout due Goldcorp CEO from Newmont deal https://seekingalpha.com/news/3423177-investors-slam-8m-payout-due-goldcorp-ceo-from-newmont-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3423177-investors-slam-8m-payout-due-goldcorp-ceo-from-newmont-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423175\" data-ts=\"1547572613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CERC\" target=\"_blank\">CERC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423175-fda-tags-three-cerecor-candidates-orphan-drugs-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA tags three Cerecor candidates Orphan Drugs; shares up 2%</a></h4><ul><li>The FDA designates the following Cerecor (<a href='https://seekingalpha.com/symbol/CERC' title='Cerecor'>CERC</a> <font color=\"green\">+2.1%</font>) candidates Orphan Drugs:</li><li><a href=\"https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=666818\" target=\"_blank\">D-galactose</a> for phosphoglucomutase 1 deficiency.</li><li><a href=\"https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=666918\" target=\"_blank\">D-mannose</a> for mannose phosphate isomerase deficiency.</li><li><a href=\"https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=667018\" target=\"_blank\">L-fucose</a> for congenital disorder of glycosylation IIc.</li><li>Among the benefits of Orphan Drug status in the U.S. is a seven-year period of market exclusivity for the indication, if approved.</li><li><strong>Update</strong>: <a href=\"https://seekingalpha.com/pr/17381773-fda-grants-cerecor-s-three-substrate-replacement-therapies-orphan-drug-designation\" target=\"_blank\">All three</a> candidates have Rare Pediatric Disease Designations.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423175\" data-linked=\"FDA tags three Cerecor candidates Orphan Drugs; shares up 2%\" data-tweet=\"$CERC - FDA tags three Cerecor candidates Orphan Drugs; shares up 2% https://seekingalpha.com/news/3423175-fda-tags-three-cerecor-candidates-orphan-drugs-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3423175-fda-tags-three-cerecor-candidates-orphan-drugs-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423171\" data-ts=\"1547572035\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PETQ\" target=\"_blank\">PETQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423171-petiq-outlook-lifts-shares-up-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PetIQ outlook lifts shares, up 11%</a></h4><ul><li>PetIQ (<a href='https://seekingalpha.com/symbol/PETQ' title='PetIQ'>PETQ</a> <font color=\"green\">+10.6%</font>) is up on below-average volume following its <a href=\"http://ir.petiq.com/phoenix.zhtml?c=254371&amp;p=irol-presentations\" target=\"_blank\">presentation </a>at the ICR Conference in Orlando, FL. Highlights:</li><li>Plans to build 1,000 new clinics by 2023. Rollout of first 34 just completed.</li><li>FY2018 sales should be ~$515M (in line with consensus). Non-GAAP EBITDA should be $40M - 45M.</li><li>Long-term targets: 15% annual sales growth; 15% non-GAAP EBITDA margin by 2023; annual non-GAAP EBITDA growth: 20%; EPS growth: 25%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423171\" data-linked=\"PetIQ outlook lifts shares, up 11%\" data-tweet=\"$PETQ - PetIQ outlook lifts shares, up 11% https://seekingalpha.com/news/3423171-petiq-outlook-lifts-shares-up-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3423171-petiq-outlook-lifts-shares-up-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423170\" data-ts=\"1547571996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/REED\" target=\"_blank\">REED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423170-reeds-leads-consumer-gainers-westport-fuel-systems-and-vuzix-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reed&#39;s leads consumer gainers; Westport Fuel Systems and Vuzix among losers</a></h4><ul><li><b>Gainers: </b>Reed's (NYSEMKT:<a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a>) <font color=\"green\">+15%</font>. Truett-Hurst (NASDAQ:<a href='https://seekingalpha.com/symbol/THST' title='Truett-Hurst, Inc.'>THST</a>) <font color=\"green\">+14%</font>. American Axle &amp; Manufacturing (NYSE:<a href='https://seekingalpha.com/symbol/AXL' title='American Axle & Manufacturing Holdings, Inc.'>AXL</a>) <font color=\"green\">+8%</font>. Summer Infant (NASDAQ:<a href='https://seekingalpha.com/symbol/SUMR' title='Summer Infant, Inc.'>SUMR</a>) <font color=\"green\">+7%</font>. Primo Water (NASDAQ:<a href='https://seekingalpha.com/symbol/PRMW' title='Primo Water'>PRMW</a>) <font color=\"green\">+7%</font></li><li><b>Losers: </b>Future FinTech Group (NASDAQ:<a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a>) <font color=\"red\">-17%</font>. Westport Fuel Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/WPRT' title='Westport Fuel Systems, Inc.'>WPRT</a>) <font color=\"red\">-7%</font>. Cooper-Standard Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CPS' title='Cooper-Standard Holdings Inc.'>CPS</a>) <font color=\"red\">-6%</font>. Dogness International (NASDAQ:<a href='https://seekingalpha.com/symbol/DOGZ' title='Dogness &#40;International&#41; Corporation Class A'>DOGZ</a>) <font color=\"red\">-6%</font><font color=\"red\">.</font><font color=\"red\"> </font>Vuzix (NASDAQ:<a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corp'>VUZI</a>) <font color=\"red\">-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423170\" data-linked=\"Reed&#39;s leads consumer gainers; Westport Fuel Systems and Vuzix among losers\" data-tweet=\"$REED $REED $THST - Reed&#39;s leads consumer gainers; Westport Fuel Systems and Vuzix among losers https://seekingalpha.com/news/3423170-reeds-leads-consumer-gainers-westport-fuel-systems-and-vuzix-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3423170-reeds-leads-consumer-gainers-westport-fuel-systems-and-vuzix-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:06 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423168\" data-ts=\"1547571853\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FB\" target=\"_blank\">FB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423168-facebook-investing-300m-for-local-news-survival\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Facebook investing $300M for local news survival</a></h4><ul>   <li>Facebook (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color=\"green\">+3.2%</font>) plans to <a href=\"https://www.reuters.com/article/us-facebook-news/facebook-to-invest-300-million-to-help-local-news-survive-idUSKCN1P9163\" target=\"_blank\">invest $300M in local news</a> over the next three years, a defense against flak that it's damaging the business.</li>    <li>The difference from prior investments is that this one isn't tied to Facebook-related products.</li>    <li>\u201cWe\u2019re going to continue fighting fake news, misinformation, and low quality news on Facebook,\u201d says Facebook's Campbell Brown \u201cBut we also have an opportunity, and a responsibility, to help local news organizations grow and thrive.\u201d</li>    <li>An early round of the investments (going to recipients like the Pulitzer Center and Report for America) will focus on boosting local reporting resources, improving newsgathering through tech, adding \"trainee community journalists\" and funding a program modeled after the Peace Corps.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3422982-buy-facebook-ahead-earnings-barclays\" target=\"_blank\">Buy Facebook ahead of earnings - Barclays</a> (Jan. 15 2019)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3423168\" data-linked=\"Facebook investing $300M for local news survival\" data-tweet=\"$FB - Facebook investing $300M for local news survival https://seekingalpha.com/news/3423168-facebook-investing-300m-for-local-news-survival?source=tweet\" data-url=\"https://seekingalpha.com/news/3423168-facebook-investing-300m-for-local-news-survival\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>58&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423166\" data-ts=\"1547571419\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/C\" target=\"_blank\">C</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423166-citigroup-surges-4_1-bmo-upgrades-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citigroup surges 4.1% as BMO upgrades to outperform</a></h4><ul><li>Citigroup (NYSE:<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a>) <font color=\"green\">jumps 4.1%</font> after BMO Capital analyst James Fotherington<a href=\"https://thefly.com/landingPageNews.php?id=2849018&amp;headline=C;MMM;RPD;AKAM;TENB;DOCU-Citi-upgrade-to-Outperform-M-price-target-cut-among-todays-top-analyst-calls\" target=\"_blank\"> upgrades the stoc</a>k to outperform, saying the bank's Q4 results and outlook were \"just fine.\"</li><li>Sees three potential upside catalysts: Access to more capital as CCAR nears; Q1 is typically its strongest quarter; benefits from a weakening dollar.</li><li>Source: The Fly.</li><li>In midday trading, Citi's intraday high of $61.40 is its highest level since Dec. 4.</li><li><a href=\"https://seekingalpha.com/symbol/C/earnings/analyst_ratings\" target=\"_blank\">Analyst ratings</a>: 20 buys, 7 holds, 1 underperform/sell; <a href=\"https://seekingalpha.com/symbol/C/earnings/estimates\" target=\"_blank\">Analyst earnings estimates</a>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3422795-citi-perks-volatility-moderates\" target=\"_blank\">Citi perks up as volatility moderates</a> (Jan. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3423166\" data-linked=\"Citigroup surges 4.1% as BMO upgrades to outperform\" data-tweet=\"$C - Citigroup surges 4.1% as BMO upgrades to outperform https://seekingalpha.com/news/3423166-citigroup-surges-4_1-bmo-upgrades-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3423166-citigroup-surges-4_1-bmo-upgrades-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423162\" data-ts=\"1547570772\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GT\" target=\"_blank\">GT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423162-goodyear-tire-rubberminus-3-after-disclosing-volume-drop\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goodyear Tire &amp; Rubber -3% after disclosing volume drop</a></h4><ul> <li>Goodyear Tire &amp; Rubber (<a href='https://seekingalpha.com/symbol/GT' title='Goodyear Tire & Rubber Co.'>GT</a> <font color='red'>-3.3%</font>) drops after the company discloses that Q4 tire unit volume fell 3% vs. a prior forecast of flat growth.</li> <li>The company cites continued weakening of the original equipment environment in China and India and notes the EMEA winter market declined late in the quarter. U.S. supply issues also led to an unfavorable mix shift during the quarter.</li><li><a href=\"https://corporate.goodyear.com/documents/events-presentations/global-auto-industry-conference-2019.pdf\" target=\"_blank\">Goodyear conference presentation slides</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3423162\" data-linked=\"Goodyear Tire &amp; Rubber -3% after disclosing volume drop\" data-tweet=\"$GT - Goodyear Tire &amp; Rubber -3% after disclosing volume drop https://seekingalpha.com/news/3423162-goodyear-tire-rubberminus-3-after-disclosing-volume-drop?source=tweet\" data-url=\"https://seekingalpha.com/news/3423162-goodyear-tire-rubberminus-3-after-disclosing-volume-drop\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423160\" data-ts=\"1547570410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARNC\" target=\"_blank\">ARNC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423160-apollo-near-deal-to-buy-arconic-for-10b-plus-wsj\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apollo near deal to buy Arconic for $10B-plus - WSJ</a></h4><ul><li>Arconic (<a href='https://seekingalpha.com/symbol/ARNC' title='Arconic Inc'>ARNC</a> <font color='green'>+3.9%</font>) spikes higher after <em>WSJ</em> reports Apollo Global Management (<a href='https://seekingalpha.com/symbol/APO' title='Apollo Global Management, LLC'>APO</a> <font color='green'>+2%</font>) is <a href=\"https://www.wsj.com/articles/apollo-nears-deal-to-buy-arconic-for-more-than-10-billion-11547569523\" target=\"_blank\">near a deal to buy the company</a> for more than $10B.</li><li>APO would pay $21-$22/share in a deal that likely will be announced this week, according to the report.</li><li>If a deal is finalized, it would end a months-long sales process for ARNC, which had a market value of ~$9.3B this morning.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423160\" data-linked=\"Apollo near deal to buy Arconic for $10B-plus - WSJ\" data-tweet=\"$ARNC $ARNC $APO - Apollo near deal to buy Arconic for $10B-plus - WSJ https://seekingalpha.com/news/3423160-apollo-near-deal-to-buy-arconic-for-10b-plus-wsj?source=tweet\" data-url=\"https://seekingalpha.com/news/3423160-apollo-near-deal-to-buy-arconic-for-10b-plus-wsj\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>94&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423155\" data-ts=\"1547570021\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423155-euro-slips-amid-dimmer-eurozone-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Euro slips amid dimmer eurozone outlook</a></h4><ul><li>The euro<font color=\"red\"> sinks 0.6%</font> against the U.S. dollar after European Central Bank President Mario Draghi says <a href=\"https://www.reuters.com/article/us-china-economy/china-signals-more-stimulus-as-economic-slowdown-deepens-idUSKCN1P9090\" target=\"_blank\">eurozone economic growth </a>is weaker than expected and uncertainties on the global front remain a factor.</li><li>\u201cA significant amount of monetary policy stimulus is still needed to support the further build-up of domestic price pressures and headline inflation developments over the medium term,\u201d he told the European Parliament.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3416831-ecb-cuts-economic-growth-forecast-ends-bond-buying-program\" target=\"_blank\">ECB cuts economic growth forecast as it ends bond-buying program</a> (Dec. 13, 2018)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/FXE' title='Invesco CurrencyShares Euro Trust ETF'>FXE</a>, <a href='https://seekingalpha.com/symbol/EUO' title='ProShares UltraShort Euro ETF'>EUO</a>, <a href='https://seekingalpha.com/symbol/ERO' title='iPath EUR/USD Exchange Rate ETN'>OTC:ERO</a>, <a href='https://seekingalpha.com/symbol/DRR' title='Market Vectors Double Short Euro ETN'>DRR</a>, <a href='https://seekingalpha.com/symbol/ULE' title='ProShares Ultra Euro ETF'>ULE</a>, <a href='https://seekingalpha.com/symbol/EUFX' title='ProShares Short Euro ETF'>EUFX</a>, <a href='https://seekingalpha.com/symbol/URR' title='Market Vectors Double Long Euro ETN'>URR</a>, <a href='https://seekingalpha.com/symbol/DEUR' title='VelocityShares Daily 4X Long USD vs. EUR ETN'>DEUR</a>, <a href='https://seekingalpha.com/symbol/UEUR' title='VelocityShares Daily 4X Long EUR vs. USD ETN'>UEUR</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3423155\" data-linked=\"Euro slips amid dimmer eurozone outlook\" data-tweet=\"$FXE $EUO $ERO - Euro slips amid dimmer eurozone outlook https://seekingalpha.com/news/3423155-euro-slips-amid-dimmer-eurozone-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3423155-euro-slips-amid-dimmer-eurozone-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423150\" data-ts=\"1547569296\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NYMX\" target=\"_blank\">NYMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423150-nymox-up-3-on-article-supporting-efficacy-of-lead-drug\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nymox up 3% on article supporting efficacy of lead drug</a></h4><ul><li>Thinly traded micro cap Nymox Pharmaceutical (<a href='https://seekingalpha.com/symbol/NYMX' title='Nymox Pharmaceutical Corporation'>NYMX</a> <font color=\"green\">+3.3%</font>) is up on average volume in apparent response to an <a href=\"https://journals.sagepub.com/doi/full/10.1177/1756287218820807\" target=\"_blank\">article</a> published in <em>Therapeutic Advances in Urology</em> supporting the value proposition of lead candidate fexapotide triflutate &#40;FT&#41; in men with benign prostatic hyperplasia &#40;BPH&#41; (enlarged prostate).</li><li>Based on results from more than 1,700 patients, FT showed long-term effects in improving BPH symptoms while demonstrating an excellent safety profile.</li><li><a href=\"http://www.nymox.com/default.action?itemid=23\" target=\"_blank\">Fexapotide triflutate</a> (NX-1207) is a pro-apoptotic (promotes cell death) protein administered directly into the prostate via a transrectal injection that does not require anesthesia or sedation.</li><li>Marketing applications are being prepared in the U.S. and Europe.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423150\" data-linked=\"Nymox up 3% on article supporting efficacy of lead drug\" data-tweet=\"$NYMX - Nymox up 3% on article supporting efficacy of lead drug https://seekingalpha.com/news/3423150-nymox-up-3-on-article-supporting-efficacy-of-lead-drug?source=tweet\" data-url=\"https://seekingalpha.com/news/3423150-nymox-up-3-on-article-supporting-efficacy-of-lead-drug\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423148\" data-ts=\"1547569212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSYS\" target=\"_blank\">SSYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423148-stratasysplus-6-on-fast-money-mention\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stratasys +6% on &quot;Fast Money&quot; mention</a></h4><ul><li>Stratasys (NASDAQ:<a href='https://seekingalpha.com/symbol/SSYS' title='Stratasys, Inc.'>SSYS</a>) gains after a positive mention on CNBC's \"Fast Money\" with Dan Nathan recommending the company as a buy.</li><li>SSYS is <font color=\"green\">up 6.3%</font> while rival 3D Systems (NYSE:<a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corp.'>DDD</a>) <font color=\"green\">gains 2.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423148\" data-linked=\"Stratasys +6% on &quot;Fast Money&quot; mention\" data-tweet=\"$SSYS $SSYS $DDD - Stratasys +6% on &quot;Fast Money&quot; mention https://seekingalpha.com/news/3423148-stratasysplus-6-on-fast-money-mention?source=tweet\" data-url=\"https://seekingalpha.com/news/3423148-stratasysplus-6-on-fast-money-mention\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423143\" data-ts=\"1547568633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423143-bank-stocks-slump-amid-disappointing-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bank stocks slump amid more disappointing earnings</a></h4><ul><li>Bank stocks wilt after disappointing earnings from Wells Fargo (<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a> <font color=\"red\">-2.5%</font>) and JPMorgan (<a href='https://seekingalpha.com/symbol/JPM' title='JPMorgan Chase & Co.'>JPM</a> <font color=\"red\">-0.9%</font>) show that Citigroup's revenue miss yesterday wasn't an outlier.</li><li>Wells Fargo, struggling from a string of scandals that started in 2016, reported Q4 revenue of $21.0B, missing consensus estimate of $21.8B.</li><li>JPMorgan's Q4 EPS missed by 23 cents and revenue also fell short of consensus as Markets &amp; Investor Services revenue--which includes fixed-income trading results--fell 29% from Q3 and 11% from a year ago.</li><li>Other banks falling: Goldman Sachs (<a href='https://seekingalpha.com/symbol/GS' title='Goldman Sachs Group Inc.'>GS</a> <font color=\"red\">-0.5%</font>), Bank of America (<a href='https://seekingalpha.com/symbol/BAC' title='Bank of America Corporation'>BAC</a> <font color=\"red\">-0.4%</font>), Morgan Stanley (<a href='https://seekingalpha.com/symbol/MS' title='Morgan Stanley'>MS</a> <font color=\"green\">+0.1%</font>).</li><li>Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color=\"green\">+3.4%</font>) gains after BMO Capital upgrades the stock to outperform from market perform.</li><li>Regional banks are also in the red: Fifth Third (<a href='https://seekingalpha.com/symbol/FITB' title='Fifth Third Bancorp'>FITB</a> <font color=\"red\">-1.2%</font>), KeyCorp (<a href='https://seekingalpha.com/symbol/KEY' title='KeyCorp'>KEY</a> <font color=\"red\">-1%</font>), Comerica (<a href='https://seekingalpha.com/symbol/CMA' title='Comerica Inc.'>CMA</a> <font color=\"red\">-0.8%</font>), PNC Financial (<a href='https://seekingalpha.com/symbol/PNC' title='PNC Financial Services Group, Inc.'>PNC</a> <font color=\"red\">-0.9%</font>), and Regions Financial (<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a> <font color=\"red\">-0.6%</font>) are among the biggest decliners.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3422992-jpmorgan-minus-1_8-percent-big-q4-eps-miss\" target=\"_blank\">JPMorgan -1.8% after big Q4 EPS miss</a> (Jan. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3423143\" data-linked=\"Bank stocks slump amid more disappointing earnings\" data-tweet=\"$WFC $WFC $JPM - Bank stocks slump amid more disappointing earnings https://seekingalpha.com/news/3423143-bank-stocks-slump-amid-disappointing-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3423143-bank-stocks-slump-amid-disappointing-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423138\" data-ts=\"1547568132\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTOV\" target=\"_blank\">KTOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423138-microbot-medical-and-chf-solutions-among-healthcare-gainers-stellar-biotechnologies-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microbot Medical and CHF Solutions among healthcare gainers; Stellar Biotechnologies and Biocept among losers</a></h4><ul><li><b>Gainers: </b>Kitov Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/KTOV' title='Kitov Pharma Ltd.'>KTOV</a>) <font color=\"green\">+125%</font>. Microbot Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a>) <font color=\"green\">+86%</font>. CHF Solutions (NASDAQ:<a href='https://seekingalpha.com/symbol/CHFS' title='CHF Solutions, Inc.'>CHFS</a>) <font color=\"green\">+23%</font>. Achieve Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a>) <font color=\"green\">+19%</font>. Tyme Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/TYME' title='Tyme Technologies, Inc.'>TYME</a>) <font color=\"green\">+19%</font>.</li><li><b>Losers: </b>Stellar Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a>) <font color=\"red\">-12%</font>. Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) <font color=\"red\">-12%</font>. Tilray (NASDAQ:<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>) <font color=\"red\">-11%</font>. Co-Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CODX' title='Co-Diagnostics'>CODX</a>) <font color=\"red\">-9%</font>. Verona Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/VRNA' title='Verona Pharma plc'>VRNA</a>) <font color=\"red\">-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423138\" data-linked=\"Microbot Medical and CHF Solutions among healthcare gainers; Stellar Biotechnologies and Biocept among losers\" data-tweet=\"$KTOV $KTOV $MBOT - Microbot Medical and CHF Solutions among healthcare gainers; Stellar Biotechnologies and Biocept among losers https://seekingalpha.com/news/3423138-microbot-medical-and-chf-solutions-among-healthcare-gainers-stellar-biotechnologies-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3423138-microbot-medical-and-chf-solutions-among-healthcare-gainers-stellar-biotechnologies-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:02 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423131\" data-ts=\"1547567352\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423131-u-s-airlines-start-to-feel-goverment-shutdown-impact\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. airlines start to feel goverment shutdown impact</a></h4><ul> <li>Delta Air Lines (<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a> <font color='red'>-0.1%</font>) is the first major airline to report earnings this year and give a glimpse on the impact of the U.S. government shutdown on the sector.</li> <li>The company cited a $25M hit to revenue in Q1, which works out to about a 25 bp cut to unit revenue.</li> <li>Bank of America Merrill Lynch is out with analysis on the Delta update. \"While the shutdown should eventually be resolved and the impact be one-time in nature, the near term impact could prove more meaningful than the $25M cited, increasing the near term revenue risk to DAL and other carriers,\" warns the BAML analyst team.</li><li>Watch for more updates on the government shutdown from Mesa Air (<a href='https://seekingalpha.com/symbol/MESA' title='Mesa Air Group'>MESA</a> <font color='green'>+1.5%</font>), American Airlines (<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a> <font color='green'>+0.9%</font>), United Continental (<a href='https://seekingalpha.com/symbol/UAL' title='United Continental Holdings, Inc'>UAL</a> <font color='green'>+1.5%</font>), Spirit Airlines (<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines'>SAVE</a>), Southwest Airlines (<a href='https://seekingalpha.com/symbol/LUV' title='Southwest Airlines Co.'>LUV</a> <font color='green'>+1.3%</font>), Hawaiian Holding (<a href='https://seekingalpha.com/symbol/HA' title='Hawaiian Holdings, Inc.'>HA</a> <font color='green'>+1.1%</font>), Alaska Air GRoup (<a href='https://seekingalpha.com/symbol/ALK' title='Alaska Air Group, Inc.'>ALK</a> <font color='green'>+0.2%</font>), SkyWest (<a href='https://seekingalpha.com/symbol/SKYW' title='SkyWest, Inc.'>SKYW</a> <font color='red'>-0.9%</font>) and Allegiant Travel (<a href='https://seekingalpha.com/symbol/ALGT' title='Allegiant Travel Company'>ALGT</a> <font color='red'>-1%</font>) as earnings season rolls along.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3423131\" data-linked=\"U.S. airlines start to feel goverment shutdown impact\" data-tweet=\"$DAL $DAL $MESA - U.S. airlines start to feel goverment shutdown impact https://seekingalpha.com/news/3423131-u-s-airlines-start-to-feel-goverment-shutdown-impact?source=tweet\" data-url=\"https://seekingalpha.com/news/3423131-u-s-airlines-start-to-feel-goverment-shutdown-impact\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423130\" data-ts=\"1547566967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423130-stock-gains-retreat-after-china-trade-comments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stock gains retreat after China trade comments</a></h4><ul><li>Major U.S. stock averages slip after U.S. Trade Representative Robert Lighthizer reports<a href=\"https://www.cnbc.com/2019/01/15/us-trade-rep-lighthizer-saw-little-progress-in-last-weeks-china-trade-talks-sen-grassley-says.html?__source=twitter%7Cmain\" target=\"_blank\"> little progress</a> in last week's talks with China last week, according to CNBC.</li><li>He says negotiators didn't make much headway in resolving structural issues and intellectual property protections.</li><li>The Dow's g<font color=\"green\">ain at 0.1%</font> slips from an early 0.5% increase. S&amp;P +<font color=\"green\">0.4%</font>, had been up as much as 0.9%. Nasdaq <font color=\"green\">+1.1%</font>, retreated the least--it had been up as much as 1.4%.</li><li>Oil <font color=\"green\">jumps 2.4%</font> to $51.71/bbl.</li><li>Dollar index <font color=\"green\">rises 0.3%</font> to 95.83.</li><li>10-year Treasury yield up half a basis point to 2.709%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423130\" data-linked=\"Stock gains retreat after China trade comments\" data-tweet=\"Stock gains retreat after China trade comments https://seekingalpha.com/news/3423130-stock-gains-retreat-after-china-trade-comments?source=tweet\" data-url=\"https://seekingalpha.com/news/3423130-stock-gains-retreat-after-china-trade-comments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423126\" data-ts=\"1547566295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAPL\" target=\"_blank\">AAPL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423126-virnetxplus-30-court-upholds-apple-award\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VirnetX +30% as court upholds Apple award</a></h4><ul><li>A U.S. appeals court <a href=\"https://www.reuters.com/article/us-apple-qualcomm-court/german-court-throws-out-qualcomms-latest-patent-case-against-apple-idUSKCN1P911C?feedType=RSS&amp;feedName=technologyNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FtechnologyNews+%28Reuters+Technology+News%29\" target=\"_blank\">upholds</a> the $440M judgement VirnetX won against Apple (<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a> <font color='green'>+1%</font>) in a patent infringement case.</li><li>Apple was appealing the 2016 jury verdict.</li><li>An administrative court ruled the same patents invalid, but VirnetX is appealing.</li><li>VHC is <font color=\"green\">up 30%</font> to $5.04.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423126\" data-linked=\"VirnetX +30% as court upholds Apple award\" data-tweet=\"$AAPL - VirnetX +30% as court upholds Apple award https://seekingalpha.com/news/3423126-virnetxplus-30-court-upholds-apple-award?source=tweet\" data-url=\"https://seekingalpha.com/news/3423126-virnetxplus-30-court-upholds-apple-award\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423124\" data-ts=\"1547566059\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VRML\" target=\"_blank\">VRML</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423124-vermillion-up-34-on-cigna-coverage-of-ova1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vermillion up 34% on Cigna coverage of OVA1</a></h4><ul><li>Thinly traded nano cap Vermillion (<a href='https://seekingalpha.com/symbol/VRML' title='Vermillion, Inc.'>VRML</a> <font color=\"green\">+33.9%</font>) is up on almost a 5x surge in volume following its <a href=\"https://seekingalpha.com/pr/17380773-vermillion-announces-coverage-cigna-ova1-mia\" target=\"_blank\">announcement </a>that Cigna added ovarian cancer test OVA1 to its preferred coverage list today.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423124\" data-linked=\"Vermillion up 34% on Cigna coverage of OVA1\" data-tweet=\"$VRML - Vermillion up 34% on Cigna coverage of OVA1 https://seekingalpha.com/news/3423124-vermillion-up-34-on-cigna-coverage-of-ova1?source=tweet\" data-url=\"https://seekingalpha.com/news/3423124-vermillion-up-34-on-cigna-coverage-of-ova1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423123\" data-ts=\"1547565966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPOT\" target=\"_blank\">SPOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423123-variety-spotify-india-launch-come-this-month\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Variety: Spotify India launch could come this month</a></h4><ul>   <li>Spotify (<a href=\"http://seekingalpha.com/symbol/SPOT\" target=\"_blank\">SPOT</a> <font color=\"green\">+3.2%</font>) could make a long-awaited debut in India as soon as the <a href=\"https://variety.com/2019/digital/news/spotify-could-launch-in-india-by-end-of-january-1203106997/\" target=\"_blank\">end of this month</a>, <i>Variety</i> reports.</li>    <li>That was thought to depend on Spotify locking down India deals with the major-label giants Sony, Universal and Warner, but it's possible that Spotify could go forward without them, according to the report.</li>    <li>And it's rumored that a launch party is already set for Mumbai on Jan. 31.</li>    <li>The company still needs additional deals with labels specializing in various regional languages; Spotify's app will be available in English but it expects to provide music in languages likely including Punjabi, Tamil, Telugu, Malayalam and Bengali.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3423123\" data-linked=\"Variety: Spotify India launch could come this month\" data-tweet=\"$SPOT - Variety: Spotify India launch could come this month https://seekingalpha.com/news/3423123-variety-spotify-india-launch-come-this-month?source=tweet\" data-url=\"https://seekingalpha.com/news/3423123-variety-spotify-india-launch-come-this-month\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423121\" data-ts=\"1547565833\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423121-pg-and-e-plunges-another-29-to-6-share\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PG&amp;E plunges another 29% to ~$6/share</a></h4><ul><li>PG&amp;E (<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='red'>-28.9%</font>) opens with another sharp drop, triggering a circuit breaker halt; shares have now lost nearly two-thirds of their market value since the company declared its intention to <a href=\"https://seekingalpha.com/news/3422615-pg-and-e-file-chapter-11-bankruptcy\" target=\"_blank\">file for Chapter 11 bankruptcy</a>.</li><li>Gov. Newsom and other California lawmakers appear to show <a href=\"https://finance.yahoo.com/news/pg-e-bailout-hopes-crushed-163848465.html\" target=\"_blank\">little interest in bailing out</a> the company.</li><li>PG&amp;E\u2019s move \u201cunderscores the reality that the state cannot regulate utilities as we have for the last 100 years,\u201d says Betty Yee, the state\u2019s controller.</li><li>The stock receives two additional downgrades, from Macquarie and Argus Research, which had previously rated PCG a Buy; entering this week, Argus, BAML, Citi, Deutsche Bank, Evercore ISI, J.P. Morgan, Macquarie and Wells Fargo had <a href=\"https://twitter.com/OpenOutcrier/status/1085180617640370177\" target=\"_blank\">continued to rate the stock a Buy</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423121\" data-linked=\"PG&amp;E plunges another 29% to ~$6/share\" data-tweet=\"$PCG - PG&amp;E plunges another 29% to ~$6/share https://seekingalpha.com/news/3423121-pg-and-e-plunges-another-29-to-6-share?source=tweet\" data-url=\"https://seekingalpha.com/news/3423121-pg-and-e-plunges-another-29-to-6-share\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>109&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423120\" data-ts=\"1547565607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VECO\" target=\"_blank\">VECO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423120-veeco-systemsplus-1_5-on-q4-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veeco Systems +1.5% on Q4 guide</a></h4><ul><li>Veeco Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/VECO' title='Veeco Instruments Inc.'>VECO</a>) will present at the Needham Growth Conference today and released its <a href=\"https://seekingalpha.com/filing/4303061\" target=\"_blank\">investor presentation</a> including Q4 guidance with revenue from $85M to $105M (consensus: $95.9M) with EPS of ($0.25) to ($0.09) (consensus: ($0.16)) at the midpoint.</li><li>Watch Veeco's conference presentation today at 3:30 PM ET <a href=\"https://ir.veeco.com/home/default.aspx\" target=\"_blank\">here</a>.</li><li>Veeco shares are<font color=\"green\"> up 1.5%</font> to $8.30.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423120\" data-linked=\"Veeco Systems +1.5% on Q4 guide\" data-tweet=\"$VECO - Veeco Systems +1.5% on Q4 guide https://seekingalpha.com/news/3423120-veeco-systemsplus-1_5-on-q4-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3423120-veeco-systemsplus-1_5-on-q4-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423116\" data-ts=\"1547564969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CARS\" target=\"_blank\">CARS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423116-cars-com-traffic-all-time-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cars.com traffic at all-time high</a></h4><ul><li>Cars.com (<a href='https://seekingalpha.com/symbol/CARS' title='Cars.com Inc.'>CARS</a> <font color='green'>+1.7%</font>) <a href=\"https://seekingalpha.com/pr/17380007-cars-com-traffic-time-high-signaling-strong-start-year-american-auto-buying-interest\" target=\"_blank\">announced</a> today twelve consecutive months of traffic gains, up 11% (y/y) in 2018, and a record-breaking month for the company, with a 21% (y/y) increase in Dec. traffic.</li><li>The company also noted a increase of 8% (y/y) in visits to its mobile app in Dec. 2018.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423116\" data-linked=\"Cars.com traffic at all-time high\" data-tweet=\"$CARS - Cars.com traffic at all-time high https://seekingalpha.com/news/3423116-cars-com-traffic-all-time-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3423116-cars-com-traffic-all-time-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423113\" data-ts=\"1547564852\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTOV\" target=\"_blank\">KTOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423113-kitov-up-60-on-encouraging-nt219-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kitov up 60% on encouraging NT219 data</a></h4><ul><li>Thinly traded nano cap Kitov Pharma (<a href='https://seekingalpha.com/symbol/KTOV' title='Kitov Pharma Ltd.'>KTOV</a> <font color=\"green\">+59.6%</font>) is up on a healthy 36x surge in volume in response to encouraging <a href=\"https://seekingalpha.com/pr/17380465-new-data-kitov-s-nt219-demonstrates-unique-mechanism-action-anti-cancer-effect\" target=\"_blank\">preclinical data</a> on cancer candidate NT219, a novel small molecule cancer drug that fights cancer by activating the \"OFF\" switch in major oncogenic pathways.</li><li>Collaborators at Hebrew University showed that NT219 binds directly to two known modulators of tumor survival, metastasis and drug resistance. The data also showed that short exposure of cancer cells to NT219 triggered irreversible shutdown of these pathways, producing a long-term anti-cancer effect.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423113\" data-linked=\"Kitov up 60% on encouraging NT219 data\" data-tweet=\"$KTOV - Kitov up 60% on encouraging NT219 data https://seekingalpha.com/news/3423113-kitov-up-60-on-encouraging-nt219-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3423113-kitov-up-60-on-encouraging-nt219-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423100\" data-ts=\"1547563870\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GMED\" target=\"_blank\">GMED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423100-device-makers-in-green-after-bsx-and-ew-settle-patent-fights\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Device makers in the green after BSX and EW settle patent fights</a></h4><ul><li>Boston Scientific and Edwards Lifesciences are leading device firms in early trade after agreeing to settle their patent disputes.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/GMED' title='Globus Medical'>GMED</a> <font color=\"green\">+1%</font>)(<a href='https://seekingalpha.com/symbol/NVRO' title='Nevro'>NVRO</a> <font color=\"green\">+1.6%</font>)(<a href='https://seekingalpha.com/symbol/ISRG' title='Intuitive Surgical, Inc.'>ISRG</a> <font color=\"green\">+2%</font>)(<a href='https://seekingalpha.com/symbol/ZBH' title='Zimmer Biomet Holdings, Inc.'>ZBH</a> <font color=\"green\">+0.9%</font>)(<a href='https://seekingalpha.com/symbol/SYK' title='Stryker Corporation'>SYK</a> <font color=\"green\">+1.3%</font>)(<a href='https://seekingalpha.com/symbol/RMD' title='ResMed Inc.'>RMD</a> <font color=\"green\">+1.4%</font>)(<a href='https://seekingalpha.com/symbol/PODD' title='Insulet Corporation'>PODD</a> <font color=\"green\">+0.9%</font>)(<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color=\"green\">+0.4%</font>)(<a href='https://seekingalpha.com/symbol/DXCM' title='DexCom, Inc.'>DXCM</a> <font color=\"green\">+0.8%</font>)(<a href='https://seekingalpha.com/symbol/BIO' title='Bio-Rad Laboratories, Inc.'>BIO</a> <font color=\"green\">+0.1%</font>)(<a href='https://seekingalpha.com/symbol/BAX' title='Baxter International Inc'>BAX</a> <font color=\"green\">+0.9%</font>)(<a href='https://seekingalpha.com/symbol/ANGO' title='AngioDynamics, Inc.'>ANGO</a> <font color=\"green\">+1%</font>)(<a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a> <font color=\"green\">+1.3%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3423100\" data-linked=\"Device makers in the green after BSX and EW settle patent fights\" data-tweet=\"$GMED $GMED $NVRO - Device makers in the green after BSX and EW settle patent fights https://seekingalpha.com/news/3423100-device-makers-in-green-after-bsx-and-ew-settle-patent-fights?source=tweet\" data-url=\"https://seekingalpha.com/news/3423100-device-makers-in-green-after-bsx-and-ew-settle-patent-fights\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423098\" data-ts=\"1547563556\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSX\" target=\"_blank\">BSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423098-boston-sci-and-edwards-rally-after-resolution-of-patient-disputes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boston Sci and Edwards rally after resolution of patient disputes</a></h4><ul><li>Boston Scientific (<a href='https://seekingalpha.com/symbol/BSX' title='Boston Scientific Corporation'>BSX</a> <font color=\"green\">+3.4%</font>) and Edwards Lifesciences (<a href='https://seekingalpha.com/symbol/EW' title='Edwards Lifesciences Corp'>EW</a> <font color=\"green\">+6%</font>) are both up in early trade after <a href=\"https://seekingalpha.com/news/3422986-boston-scientific-edwards-lifesciences-settle-global-patent-disputes\" target=\"_blank\">settling </a>their global patent rows.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423098\" data-linked=\"Boston Sci and Edwards rally after resolution of patient disputes\" data-tweet=\"$BSX $BSX $EW - Boston Sci and Edwards rally after resolution of patient disputes https://seekingalpha.com/news/3423098-boston-sci-and-edwards-rally-after-resolution-of-patient-disputes?source=tweet\" data-url=\"https://seekingalpha.com/news/3423098-boston-sci-and-edwards-rally-after-resolution-of-patient-disputes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423097\" data-ts=\"1547563350\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MU\" target=\"_blank\">MU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423097-micron-fcf-sustainable-says-wells-fargo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Micron FCF sustainable, says Wells Fargo</a></h4><ul><li>Wells Fargo analyst Aaron Rakers says Micron (<a href='https://seekingalpha.com/symbol/MU' title='Micron Technology Inc.'>MU</a> <font color='green'>+0.8%</font>) can sustain positive FCF at downturn levels similar to 2009.</li><li>Rakers' comments follow a meeting with Micron's CFO. The analyst says concerns over the first quarter inventory build are driven by NAND versus DRAM inventory, but Micron is comfortable it can manage inventory normalization.</li><li>The firm lowers its Micron 2019 and 2020 EPS and revenue estimates.</li><li>Source: Bloomberg First Word.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423097\" data-linked=\"Micron FCF sustainable, says Wells Fargo\" data-tweet=\"$MU - Micron FCF sustainable, says Wells Fargo https://seekingalpha.com/news/3423097-micron-fcf-sustainable-says-wells-fargo?source=tweet\" data-url=\"https://seekingalpha.com/news/3423097-micron-fcf-sustainable-says-wells-fargo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:42 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>92&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423089\" data-ts=\"1547562271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NFLX\" target=\"_blank\">NFLX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423089-netflixplus-5-on-report-of-price-hikes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Netflix +5% on report of price hikes</a></h4><ul> <li>Netflix (NASDAQ:<a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>) is hiking <a href=\"https://hosted.ap.org/article/76214d0d5b1a4d0890a2d3040a3ddb33/netflix-raising-prices-58m-us-subscribers-costs-rise\" target=\"_blank\">prices</a> by 13% to 18%, according to Associated Press.</li> <li>AP's Michael Liedtje says the increase is the largest by the company in 12 years.</li> <li>The price increases in the U.S. include a bump on the most popular plan to $13 per month from $11 and an increase in the premium ultra-high def service to $16 from $14.</li> <li>Shares of Netflix are <font color=\"green\">up 5.13%</font> in premarket trading to $350.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3423089\" data-linked=\"Netflix +5% on report of price hikes\" data-tweet=\"$NFLX - Netflix +5% on report of price hikes https://seekingalpha.com/news/3423089-netflixplus-5-on-report-of-price-hikes?source=tweet\" data-url=\"https://seekingalpha.com/news/3423089-netflixplus-5-on-report-of-price-hikes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>223&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423086\" data-ts=\"1547561920\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MBOT\" target=\"_blank\">MBOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423086-microbot-down-3-premarket-on-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microbot down 3% premarket on stock offering</a></h4><ul><li>Nano cap Microbot Medical (NASDAQ:<a href='https://seekingalpha.com/symbol/MBOT' title='Microbot Medical Inc'>MBOT</a>) slips <font color=\"red\">3%</font> premarket on robust volume in response to its <a href=\"https://seekingalpha.com/pr/17380212-microbot-medical-inc-announces-3-million-registered-direct-offering-priced-market\" target=\"_blank\">direct offering</a> of 455,323 common shares at $6.50 per share to an institutional investor, a discount of 34% from yesterday's close of $9.79, despite the company regarding the offering as \"at-the-market.\"</li><li><strong>Update</strong>: The company <a href=\"https://seekingalpha.com/pr/17381214-microbot-medical-inc-announces-5_9-million-registered-direct-offering-priced-market\" target=\"_blank\">announced </a>that it inked deals with several institutional investors for the purchase of 590K shares at $10 per share.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423086\" data-linked=\"Microbot down 3% premarket on stock offering\" data-tweet=\"$MBOT - Microbot down 3% premarket on stock offering https://seekingalpha.com/news/3423086-microbot-down-3-premarket-on-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3423086-microbot-down-3-premarket-on-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423084\" data-ts=\"1547561812\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KTOV\" target=\"_blank\">KTOV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423084-ssys-arry-among-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SSYS, ARRY among premarket gainers</a></h4><ul><li>Kitov Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/KTOV' title='Kitov Pharma Ltd.'>KTOV</a>) <font color=\"green\">+60%</font> on new findings from its ongoing collaboration with researchers from the Hebrew University  of Jerusalem revealing NT219\u2019s high affinity and selective binding to its target proteins.</li><li>Ability (NASDAQ:<a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a>) <font color=\"green\">+27%</font>.</li><li>Safe-T Group (NASDAQ:<a href='https://seekingalpha.com/symbol/SFET' title='Safe-T Group Ltd Sponsored ADR'>SFET</a>) <font color=\"green\">+18%</font> on <a href=\"https://seekingalpha.com/pr/17379785-safe-t-data-joins-symantec-technology-integration-partner-program\" target=\"_blank\">joining</a> the Symantec Technology Integration Partner Program.</li><li>Blue Apron Holdings (NYSE:<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a>) <font color=\"green\">+8%</font> after <a href=\"https://seekingalpha.com/news/3423029-blue-apron-plus-11-percent-update\" target=\"_blank\">update</a>.</li><li>New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color=\"green\">+6%</font>.</li><li>TransEnterix (NYSEMKT:<a href='https://seekingalpha.com/symbol/TRXC' title='TransEnterix, Inc.'>TRXC</a>) <font color=\"green\">+6%</font> on <a href=\"https://seekingalpha.com/pr/17379930-transenterix-receives-fda-510-k-clearance-senhance-ultrasonic-system\" target=\"_blank\">FDA clearance</a> for senhance ultrasonic system.</li><li>Stratasys (NASDAQ:<a href='https://seekingalpha.com/symbol/SSYS' title='Stratasys, Inc.'>SSYS</a>) <font color=\"green\">+6%</font>.</li><li>Achieve Life Sciences (NASDAQ:<a href='https://seekingalpha.com/symbol/ACHV' title='Achieve Life Sciences, Inc.'>ACHV</a>) <font color=\"green\">+6%</font>.</li><li>SAExploration Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a>) <font color=\"green\">+6%</font>.</li><li>Array BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a>) <font color=\"green\">+5%</font> on <a href=\"https://seekingalpha.com/news/3423051-goldman-likes-incyte-premarket-analyst-action\" target=\"_blank\">analyst upgrade</a> and on <a href=\"https://seekingalpha.com/news/3423001-array-bio-11-percent-premarket-positive-late-stage-data-triplet-therapy-certain-type\" target=\"_blank\">positive late-stage data</a> on triplet therapy for certain type of colorectal cancer.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423084\" data-linked=\"SSYS, ARRY among premarket gainers\" data-tweet=\"$KTOV $KTOV $ABIL - SSYS, ARRY among premarket gainers https://seekingalpha.com/news/3423084-ssys-arry-among-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3423084-ssys-arry-among-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423083\" data-ts=\"1547561703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423083-amdplus-1-on-rumors-of-intel-interest\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD +1% on rumors of Intel interest</a></h4><ul><li>AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) and Intel (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) gain after an<a href=\"https://www.eetimes.com/author.asp?section_id=36&amp;doc_id=1334179\" target=\"_blank\"> EE Times</a> report of a CES rumor that Intel is considering acquiring AMD.</li><li>Analysts dismiss the idea outright and say the FTC would never allow the deal.</li><li>AMD shares are <font color=\"green\">up 1.4%</font> premarket to $20.52.</li><li>INTC is <font color=\"green\">up 0.1%</font> to $48.41.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423083\" data-linked=\"AMD +1% on rumors of Intel interest\" data-tweet=\"$AMD $AMD $INTC - AMD +1% on rumors of Intel interest https://seekingalpha.com/news/3423083-amdplus-1-on-rumors-of-intel-interest?source=tweet\" data-url=\"https://seekingalpha.com/news/3423083-amdplus-1-on-rumors-of-intel-interest\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>197&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423078\" data-ts=\"1547561444\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOC\" target=\"_blank\">BIOC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423078-shw-bioc-and-alny-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SHW, BIOC and ALNY among premarket losers</a></h4><ul><li>Biocept (NASDAQ:<a href='https://seekingalpha.com/symbol/BIOC' title='Biocept, Inc.'>BIOC</a>) <font color=\"red\">-20%</font>.</li><li>PG&amp;E (NYSE:<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a>) <font color=\"red\">-19%</font>.</li><li>Stellar Biotechnologies (NASDAQ:<a href='https://seekingalpha.com/symbol/SBOT' title='Stellar Biotechnologies Inc.'>SBOT</a>) <font color=\"red\">-8%</font>.</li><li>Alnylam Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a>) <font color=\"red\">-7%</font> on <a href=\"https://seekingalpha.com/news/3422960-alnylam-pharmaceuticals-lower-4-percent-pricing-public-offering-common-stock\" target=\"_blank\">pricing</a> common stock offering.</li><li>The Sherwin-Williams (NYSE:<a href='https://seekingalpha.com/symbol/SHW' title='The Sherwin-Williams Company'>SHW</a>) <font color=\"red\">-5%</font> after soft <a href=\"https://seekingalpha.com/news/3422988-sherwin-williams-watch-soft-guidance-update\" target=\"_blank\">guidance</a> update.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3423078\" data-linked=\"SHW, BIOC and ALNY among premarket losers\" data-tweet=\"$BIOC $BIOC $PCG - SHW, BIOC and ALNY among premarket losers https://seekingalpha.com/news/3423078-shw-bioc-and-alny-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3423078-shw-bioc-and-alny-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423073\" data-ts=\"1547561282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYTU\" target=\"_blank\">AYTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423073-aytu-bio-launches-new-cough-medicine-in-u-s-shares-up-29-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aytu Bio launches new cough medicine in U.S., shares up 29% premarket</a></h4><ul><li>Nano cap Aytu BioScience (NASDAQ:<a href='https://seekingalpha.com/symbol/AYTU' title='Aytu BioScience, Inc.'>AYTU</a>) is up <font color=\"green\">29%</font> premarket on increased volume following its <a href=\"https://seekingalpha.com/pr/17380308-aytu-bioscience-announces-u-s-field-sales-launch-tuzistra-r-xr\" target=\"_blank\">announced </a>U.S. launch of Tuzistra XR, a 12-hour codeine-based cough suppressant.</li><li>The company in-licensed the product from Tris Pharma about two months ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423073\" data-linked=\"Aytu Bio launches new cough medicine in U.S., shares up 29% premarket\" data-tweet=\"$AYTU - Aytu Bio launches new cough medicine in U.S., shares up 29% premarket https://seekingalpha.com/news/3423073-aytu-bio-launches-new-cough-medicine-in-u-s-shares-up-29-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3423073-aytu-bio-launches-new-cough-medicine-in-u-s-shares-up-29-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423070\" data-ts=\"1547561212\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALB\" target=\"_blank\">ALB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423070-albemarle-livent-downgraded-nomura-on-price-data-point-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Albemarle, Livent downgraded at Nomura on price data point outlook</a></h4><ul><li>Albemarle (NYSE:<a href='https://seekingalpha.com/symbol/ALB' title='Albemarle Corporation'>ALB</a>) <font color=\"red\">-1.8%</font> pre-market after Nomura <a href=\"https://www.streetinsider.com/Analyst+Comments/NomuraInstinet+Downgrades+Albemarle+%28ALB%29+to+Neutral/15006087.html\" target=\"_blank\">downgrades</a> the stock and lithium producing peer Livent (NYSE:<a href='https://seekingalpha.com/symbol/LTHM' title='Livent'>LTHM</a>) to Neutral from Buy, expecting \"price data points to surprise  negatively in coming months... [which] could drive ALB and LTHM trading multiples lower.\"</li><li>Nomura analyst Aleksey Yefremov cuts his stock price target for ALB to $85 from $90 while maintaining his LTHM price target at $16.</li><li>But with more stable pricing than peers, Nomura still views ALB and LTHM as more attractive than the broader lithium industry.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423070\" data-linked=\"Albemarle, Livent downgraded at Nomura on price data point outlook\" data-tweet=\"$ALB $ALB $LTHM - Albemarle, Livent downgraded at Nomura on price data point outlook https://seekingalpha.com/news/3423070-albemarle-livent-downgraded-nomura-on-price-data-point-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3423070-albemarle-livent-downgraded-nomura-on-price-data-point-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:06 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423056\" data-ts=\"1547559919\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNY\" target=\"_blank\">SNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423056-fda-ad-com-approaches-for-sanofi-and-lexicons-sotagliflozin\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA Ad Com approaches for Sanofi and Lexicon&#39;s sotagliflozin</a></h4><ul><li>The FDA's Endocrinologic and Metabolic Drugs Advisory Committee will <a href=\"https://www.fda.gov/AdvisoryCommittees/Calendar/ucm627271.htm\" target=\"_blank\">meet</a> on Thursday, January 17, to review and discuss Sanofi's (NASDAQ:<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a>) marketing application seeking approval for orally administered Zynquista (sotagliflozin) as an adjunct to insulin to improve glycemic control in adults with type 1 diabetes.</li><li>Shares are up <font color=\"green\">1%</font> premarket while co-development partner Lexicon Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/LXRX' title='Lexicon Pharmaceuticals, Inc.'>LXRX</a>) is up <font color=\"green\">2%</font>.</li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM629485.pdf\" target=\"_blank\">FDA briefing doc</a></li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM629486.pdf\" target=\"_blank\">Errata to FDA briefing doc</a></li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/EndocrinologicandMetabolicDrugsAdvisoryCommittee/UCM629487.pdf\" target=\"_blank\">Sanofi briefing doc </a></li></ul><div class=\"tiny-share-widget\" data-id=\"3423056\" data-linked=\"FDA Ad Com approaches for Sanofi and Lexicon&#39;s sotagliflozin\" data-tweet=\"$SNY $SNY $LXRX - FDA Ad Com approaches for Sanofi and Lexicon&#39;s sotagliflozin https://seekingalpha.com/news/3423056-fda-ad-com-approaches-for-sanofi-and-lexicons-sotagliflozin?source=tweet\" data-url=\"https://seekingalpha.com/news/3423056-fda-ad-com-approaches-for-sanofi-and-lexicons-sotagliflozin\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423055\" data-ts=\"1547559903\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WFC\" target=\"_blank\">WFC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423055-wells-fargo-q4-reflects-loan-growth-lower-taxes\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo Q4 reflects loan growth, lower taxes</a></h4><ul><li>Wells Fargo (NYSE:<a href='https://seekingalpha.com/symbol/WFC' title='Wells Fargo & Co.'>WFC</a>)<a href=\"https://seekingalpha.com/pr/17380203-wells-fargo-reports-6_1-billion-quarterly-net-income-diluted-eps-1_21\" target=\"_blank\"> Q4 EPS</a> of $1.21 beats consensus estimate of $1.20, compares with $1.13 in Q3 and $1.16 in the year-ago quarter.</li><li>Reflects growth in loans and deposits; credit performance remained strong, says CFO John Shrewsberry. Effective income tax rate was lower vs. Q3.</li><li>Wells Fargo<font color=\"red\"> slips 1.2%</font> in premarket trading.</li><li>\"We continued to have positive business trends in the fourth quarter with primary consumer checking customers, consumer credit card active accounts, debit and credit card usage, commercial loan balances, and loan originations in auto, small business, home equity and student lending all growing compared with a year ago,\" Shrewsberry says.</li><li>Q4 net interest margin of 2.94%, unchanged from Q3, and vs. 2.84% in Q4 2017.</li><li>Q4 effective income tax rate was 13.7% vs. 20.1% in Q3.</li><li>Q4 mortgage banking income of $467M fell from $846M in Q3.</li><li>Total average loans were $946.3B in Q4, up $6.9B form Q3.</li><li>Total average deposits $1.3T, up $2.6B from Q3.</li><li>Allowance for credit losses $10.7B at Dec. 31, 2018, down $249M from Sept. 30, 2018.</li><li>Community Banking net income of $3.17B vs. $2.82B in Q3 and $3.47B in Q4 2017.</li><li>Wholesale Banking net income was $2.67B vs. $2.85B in Q3 and $2.37B in Q4 2017.</li><li>Wealth and Investment Management net income of $689M vs. $732M in Q3 and $675M in Q4 2017.</li><li>Return on equity 12.89% vs. 12.04% in Q3 and 12.47% a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3423015-wells-fargo-beats-0_01-misses-revenue\" target=\"_blank\">Wells Fargo beats by $0.01, misses on revenue</a> (Jan. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3423055\" data-linked=\"Wells Fargo Q4 reflects loan growth, lower taxes\" data-tweet=\"$WFC - Wells Fargo Q4 reflects loan growth, lower taxes https://seekingalpha.com/news/3423055-wells-fargo-q4-reflects-loan-growth-lower-taxes?source=tweet\" data-url=\"https://seekingalpha.com/news/3423055-wells-fargo-q4-reflects-loan-growth-lower-taxes\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423051\" data-ts=\"1547559507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423051-goldman-likes-incyte-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Goldman likes Incyte in premarket analyst action</a></h4><ul><li>Array BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a>) initiated with Overweight rating and $30 (76% upside) price target. Shares are up <font color=\"green\">9%</font> premarket on late-stage Mektovi/Braftovi data.</li><li>Incyte (NASDAQ:<a href='https://seekingalpha.com/symbol/INCY' title='Incyte Corporation'>INCY</a>) added to Conviction List with a $111 (51% upside) price target at Goldman Sachs citing M&amp;A possibilities. Shares up <font color=\"green\">3% </font>premarket.</li><li>MEDNAX (NYSE:<a href='https://seekingalpha.com/symbol/MD' title='Mednax, Inc.'>MD</a>) upgraded to Buy at Citigroup.</li><li>Medtronic (NYSE:<a href='https://seekingalpha.com/symbol/MDT' title='Medtronic plc'>MDT</a>) upgraded to Buy with a $100 (18% upside) price target at BTIG Research. Shares up <font color=\"green\">1%</font> premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423051\" data-linked=\"Goldman likes Incyte in premarket analyst action\" data-tweet=\"$ARRY $ARRY $INCY - Goldman likes Incyte in premarket analyst action https://seekingalpha.com/news/3423051-goldman-likes-incyte-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3423051-goldman-likes-incyte-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423040\" data-ts=\"1547559069\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORCL\" target=\"_blank\">ORCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423040-oracleminus-1-on-morgan-stanley-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oracle -1% on Morgan Stanley downgrade</a></h4><ul><li>Oracle (NYSE:<a href='https://seekingalpha.com/symbol/ORCL' title='Oracle Corporation'>ORCL</a>)<font color=\"red\"> drops 1.1% </font>premarket after Morgan Stanley <a href=\"https://www.cnbc.com/2019/01/15/stocks-making-the-biggest-moves-premarket-jpm-unh-dal-aapl-tlry--more.html\" target=\"_blank\">downgrades</a> the company from Overweight to Equal-Weight citing a lack of catalysts.</li><li>Oracle has 16 Buy-equivalent <a href=\"https://seekingalpha.com/symbol/ORCL/earnings/analyst_ratings\" target=\"_blank\">analyst ratings</a>, 20 Holds, and one each of Underperform and Sell. The average price target is $52.45.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423040\" data-linked=\"Oracle -1% on Morgan Stanley downgrade\" data-tweet=\"$ORCL - Oracle -1% on Morgan Stanley downgrade https://seekingalpha.com/news/3423040-oracleminus-1-on-morgan-stanley-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3423040-oracleminus-1-on-morgan-stanley-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423038\" data-ts=\"1547559016\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEEL\" target=\"_blank\">SEEL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423038-apricus-biosciences-to-merge-seelos-therapeutics-shares-up-6-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apricus Biosciences to merge with Seelos Therapeutics; shares up 6% premarket</a></h4><ul><li>Apricus Biosciences (APRI) is up <font color=\"green\">6%</font> on <a href=\"https://seekingalpha.com/pr/17380011-apricus-biosciences-stockholders-approve-proposed-merger-seelos-therapeutics-inc\" target=\"_blank\">signing</a> merger agreement with Seelos Therapeutics. Over 95% of the votes cast were in favor of the merger with Seelos and over 85% were in favor of the reverse stock split.</li>       <li>Under the terms of agreement, the holders of Seelos\u2019 outstanding capital stock will receive common shares of Apricus upon closing of merger.</li><li>Seelos and Apricus stockholders are expected to own ~85% and ~15%, respectively of the merged company.</li>  <li>Upon closing, current Apricus stockholders will receive one Contingent Value Right &#40;CVR&#41; per share of Apricus common stock owned.</li>  <li>The proposed merger is expected to close in January 2019.</li>    </ul><div class=\"tiny-share-widget\" data-id=\"3423038\" data-linked=\"Apricus Biosciences to merge with Seelos Therapeutics; shares up 6% premarket\" data-tweet=\"$SEEL - Apricus Biosciences to merge with Seelos Therapeutics; shares up 6% premarket https://seekingalpha.com/news/3423038-apricus-biosciences-to-merge-seelos-therapeutics-shares-up-6-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3423038-apricus-biosciences-to-merge-seelos-therapeutics-shares-up-6-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423034\" data-ts=\"1547558589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THC\" target=\"_blank\">THC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423034-tenet-inks-new-contract-humana-shares-up-2-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tenet inks new contract with Humana; shares up 2% premarket</a></h4><ul><li>Tenet Healthcare (NYSE:<a href='https://seekingalpha.com/symbol/THC' title='Tenet Healthcare Corporation'>THC</a>) is up <font color=\"green\">2%</font> premarket on light volume on the heels of its new multiyear <a href=\"https://seekingalpha.com/pr/17380186-tenet-humana-sign-multi-year-agreement\" target=\"_blank\">agreement </a>with Humana (NYSE:<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a>) providing in-network access to THC's hospitals, outpatients centers and doctors. The contract will be in effect through May 2023. Financial terms are not disclosed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423034\" data-linked=\"Tenet inks new contract with Humana; shares up 2% premarket\" data-tweet=\"$THC $THC $HUM - Tenet inks new contract with Humana; shares up 2% premarket https://seekingalpha.com/news/3423034-tenet-inks-new-contract-humana-shares-up-2-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3423034-tenet-inks-new-contract-humana-shares-up-2-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423029\" data-ts=\"1547558364\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APRN\" target=\"_blank\">APRN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423029-blue-apronplus-11-after-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Blue Apron +11% after update</a></h4><ul> <li>Blue Apron (<a href='https://seekingalpha.com/symbol/APRN' title='Blue Apron Holdings, Inc.'>APRN</a> <font color='red'>-2.8%</font>) tips off some announcements that it will make with earnings on January 31.</li><li>The company says it plans to reaffirm       confidence in achieving profitability on an adjusted EBITDA basis both       in the Q1 of 2019 and for the full year 2019 as it actively       pursues the appropriate strategies to create value for its stakeholders.</li><li>Blue Apron also plans to update on product innovations and new consumer engagement strategies.</li><li>APRN  <font color=\"green\">+11.44%</font> premarket to  $1.16.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17380040-blue-apron-provide-update-strategic-initiatives-release-fourth-quarter-fiscal-2018-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3423029\" data-linked=\"Blue Apron +11% after update\" data-tweet=\"$APRN - Blue Apron +11% after update https://seekingalpha.com/news/3423029-blue-apronplus-11-after-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3423029-blue-apronplus-11-after-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423017\" data-ts=\"1547557542\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYOS\" target=\"_blank\">MYOS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423017-myos-rens-up-30-on-positive-data-in-study-evaluating-fortetropin-for-muscle-atrophy-in-dogs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Myos Rens up 30% on positive data in study evaluating Fortetropin for muscle atrophy in dogs</a></h4><ul><li>MYOS RENS Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/MYOS' title='MYOS RENS Technology'>MYOS</a>) is up <font color=\"green\">30%</font> on <a href=\"https://seekingalpha.com/pr/17380008-myos-rens-technology-announces-study-results-demonstrating-fortetropin-active-ingredient-myos\" target=\"_blank\">announcing</a> positive top-line results from a study evaluating the impact of Fortetropin on attenuating muscle atrophy following a common surgical procedure known as tibial-plateau leveling osteotomy in 100 dogs.</li><li>The objective of the study was to determine whether Fortetropin could reduce muscle atrophy.</li><li>Fortetropin prevented the loss of muscle mass in these dogs and a more significant improvement in percentage of weight supported by the affected limb was observed as compared to the placebo group.</li><li>Fortetropin also prevented a rise in serum myostatin levels.</li><li>An oral summary of study results will be presented on January 20, at the North American Veterinary Community/VMX Conference in Orlando, Florida.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423017\" data-linked=\"Myos Rens up 30% on positive data in study evaluating Fortetropin for muscle atrophy in dogs\" data-tweet=\"$MYOS - Myos Rens up 30% on positive data in study evaluating Fortetropin for muscle atrophy in dogs https://seekingalpha.com/news/3423017-myos-rens-up-30-on-positive-data-in-study-evaluating-fortetropin-for-muscle-atrophy-in-dogs?source=tweet\" data-url=\"https://seekingalpha.com/news/3423017-myos-rens-up-30-on-positive-data-in-study-evaluating-fortetropin-for-muscle-atrophy-in-dogs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423001\" data-ts=\"1547556904\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRY\" target=\"_blank\">ARRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423001-array-bio-up-11-premarket-on-positive-late-stage-data-on-triplet-therapy-for-certain-type-of\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Array Bio up 11% premarket on positive late-stage data on triplet therapy for certain type of colorectal cancer</a></h4><ul><li>Array BioPharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a>) is up <font color=\"green\">11%</font> premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17379648-array-biopharma-announces-15_3-months-median-overall-survival-safety-lead-phase-3-beacon-crc\" target=\"_blank\">announcement </a>of updated data from a Phase 3 clinical trial, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02928224?lead=array+biopharma&amp;phase=2&amp;rank=2\" target=\"_blank\">BEACON CRC</a>, evaluating the combination of BRAFTOVI (encorafenib), MEKTOVI (binimetinib) and Eli Lilly's ERBITUX (cetuximab) in patients with BRAF-V600E-positive metastatic colorectal cancer &#40;CRC&#41;. The results will be presented at the ASCO GI Cancers Symposium in San Francisco.</li><li>Median overall survival &#40;OS&#41; was 15.3 months. Median progression-free survival &#40;PFS&#41; was eight months and the overall response rate &#40;ORR&#41; was 48%.</li><li>No new safety signals were observed.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423001\" data-linked=\"Array Bio up 11% premarket on positive late-stage data on triplet therapy for certain type of colorectal cancer\" data-tweet=\"$ARRY - Array Bio up 11% premarket on positive late-stage data on triplet therapy for certain type of colorectal cancer https://seekingalpha.com/news/3423001-array-bio-up-11-premarket-on-positive-late-stage-data-on-triplet-therapy-for-certain-type-of?source=tweet\" data-url=\"https://seekingalpha.com/news/3423001-array-bio-up-11-premarket-on-positive-late-stage-data-on-triplet-therapy-for-certain-type-of\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3423003\" data-ts=\"1547555996\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CTRL\" target=\"_blank\">CTRL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3423003-conrol4minus-5-on-raymond-james-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Conrol4 -5% on Raymond James downgrade</a></h4><ul><li>Raymond James downgrades Control4 (NASDAQ:<a href='https://seekingalpha.com/symbol/CTRL' title='Control4 Corporation'>CTRL</a>) from Outperform to Market Perform. (Source: Bloomberg First Word)</li><li>The downgrade follows a <font color=\"red\">28%</font> pullback in the past quarter on tariff risks and soft housing starts.</li><li>Control4 has 7 Buy-equivalent <a href=\"https://seekingalpha.com/symbol/CTRL/earnings/analyst_ratings\" target=\"_blank\">analyst ratings</a> and 2 Holds with an average price target of $31.75.</li><li>CTRL is <font color=\"red\">down 5.2%</font> premarket to $18.25.</li></ul><div class=\"tiny-share-widget\" data-id=\"3423003\" data-linked=\"Conrol4 -5% on Raymond James downgrade\" data-tweet=\"$CTRL - Conrol4 -5% on Raymond James downgrade https://seekingalpha.com/news/3423003-conrol4minus-5-on-raymond-james-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3423003-conrol4minus-5-on-raymond-james-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3422998\" data-ts=\"1547555687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARR\" target=\"_blank\">ARR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3422998-armour-residentialminus-3_1-after-stock-offering-upsized\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ARMOUR Residential -3.1% after stock offering upsized</a></h4><ul><li>ARMOUR Residential REIT (NYSE:<a href='https://seekingalpha.com/symbol/ARR' title='ARMOUR Residential REIT, Inc.'>ARR</a>) <font color=\"red\">slides 3.1%</font> in premarket trading after it boosts the size of its<a href=\"https://seekingalpha.com/pr/17379934-armour-residential-reit-inc-announces-pricing-upsized-public-offering-6000-000-shares-common\" target=\"_blank\"> common stock offering</a> to 6M shares from 5M.</li><li>Offering prices at $20.41 per share; ARR closed Monday at $21.04.</li><li>Greenshoe option for up to 900K additional shares.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3422897-armour-residential-minus-2_1-percent-5m-share-offering-launches\" target=\"_blank\">ARMOUR Residential -2.1% after 5M-share offering launches</a> (Jan. 14)</li></ul><div class=\"tiny-share-widget\" data-id=\"3422998\" data-linked=\"ARMOUR Residential -3.1% after stock offering upsized\" data-tweet=\"$ARR - ARMOUR Residential -3.1% after stock offering upsized https://seekingalpha.com/news/3422998-armour-residentialminus-3_1-after-stock-offering-upsized?source=tweet\" data-url=\"https://seekingalpha.com/news/3422998-armour-residentialminus-3_1-after-stock-offering-upsized\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3422997\" data-ts=\"1547555575\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MUX\" target=\"_blank\">MUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3422997-mcewen-miningplus-2-2018-production-tops-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McEwen Mining +2% as 2018 production tops guidance</a></h4><ul><li>McEwen Mining (NYSE:<a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a>) <font color=\"green\">+2.2%</font> pre-market after reporting <a href=\"https://seekingalpha.com/pr/17379915-mcewen-mining-reports-2018-full-year-q4-production-results\" target=\"_blank\">FY 2018 production exceeded guidance</a>, with gold equiv. output of 175.5K oz. rising 15% Y/Y and beating the company's outlook of 171K oz.</li><li>Full-year production included 135.1K oz. of gold, up 23% Y/Y, and 3.03M oz. of silver, 4.5% lower than the previous tear.</li><li>MUX says 2018 production at its 100%-owned Black Fox mine in Canada totaled 48.8K gold equiv. oz., in line with guidance of 48K gold equiv. oz., and output at its 100%-owned El Gallo project in Mexico of 39K gold. equiv. oz. topped guidance of 32K oz.</li><li>MUX also says construction at the Gold Bar mine in Nevada is near completion and on schedule for inaugural gold production in Q1.</li></ul><div class=\"tiny-share-widget\" data-id=\"3422997\" data-linked=\"McEwen Mining +2% as 2018 production tops guidance\" data-tweet=\"$MUX - McEwen Mining +2% as 2018 production tops guidance https://seekingalpha.com/news/3422997-mcewen-miningplus-2-2018-production-tops-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3422997-mcewen-miningplus-2-2018-production-tops-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3422991\" data-ts=\"1547554954\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BOX\" target=\"_blank\">BOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3422991-boxplus-1_7-rosenblatt-leaves-sidelines\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Box +1.7% as Rosenblatt leaves sidelines</a></h4><ul><li>Rosenblatt upgrades Box (NYSE:<a href='https://seekingalpha.com/symbol/BOX' title='Box'>BOX</a>) from Neutral to Buy and raises the target from $25 to $27, a 45% upside to yesterday's close. (Source: Bloomberg First Word)</li><li>Box shares are down 16% in the past year but made it through last quarter's tech rout down only 1.4% partly due to <a href=\"https://seekingalpha.com/news/3420041-box-plus-6_5-percent-renewed-m-chatter\" target=\"_blank\">M&amp;A</a><a href=\"https://seekingalpha.com/news/3419272-analyst-picks-likely-pe-targets-mindbody-sale\" target=\"_blank\"> speculation</a>.</li><li>Box has 10 Buy-equivalent <a href=\"https://seekingalpha.com/symbol/BOX/earnings/analyst_ratings\" target=\"_blank\">analyst ratings </a>and 5 Holds with an average price target of $25.77.</li><li>Box shares are <font color=\"green\">up 1.7%</font> premarket to $18.90.</li></ul><div class=\"tiny-share-widget\" data-id=\"3422991\" data-linked=\"Box +1.7% as Rosenblatt leaves sidelines\" data-tweet=\"$BOX - Box +1.7% as Rosenblatt leaves sidelines https://seekingalpha.com/news/3422991-boxplus-1_7-rosenblatt-leaves-sidelines?source=tweet\" data-url=\"https://seekingalpha.com/news/3422991-boxplus-1_7-rosenblatt-leaves-sidelines\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}